FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

José Gatell

Research Profile

Disorders

Living Beings

HIV-1

Procedures

Concepts & Ideas

Chemicals & Drugs

Geographic Areas

Spain

Co-author Network

Publications

TOP 3
H Arberas; M E Bargalló; J L Blanco; M Calvo; Felipe García; José M Gatell; A C Guardo; María J Maleno; Montserrat Plana
In vitro effects of the CCR5 inhibitor maraviroc on human T cell function.
Mar Masiá; Sergio Padilla; José M Gatell; Esteban Martínez; Félix Gutiérrez
Endothelial function in HIV-infected patients switching from a boosted protease inhibitor-based regimen to raltegravir: a substudy of the SPIRAL study.
Esteban Martínez; Ignacio Pérez; Judit Pich; Polyana M d'Albuquerque; José M Gatell
Abacavir/lamivudine versus tenofovir/emtricitabine in virologically suppressed patients switching from ritonavir-boosted protease inhibitors to raltegravir.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of José Gatell (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: H Arberas; M E Bargalló; J L Blanco; M Calvo; Felipe García; José M Gatell; A C Guardo; María J Maleno; Montserrat Plana
In vitro effects of the CCR5 inhibitor maraviroc on human T cell function.
The Journal of antimicrobial chemotherapy 2013;68(3):577-86.
2013: Mar Masiá; Sergio Padilla; José M Gatell; Esteban Martínez; Félix Gutiérrez
Endothelial function in HIV-infected patients switching from a boosted protease inhibitor-based regimen to raltegravir: a substudy of the SPIRAL study.
The Journal of antimicrobial chemotherapy 2013;68(2):409-13.
2013: Esteban Martínez; Ignacio Pérez; Judit Pich; Polyana M d'Albuquerque; José M Gatell
Abacavir/lamivudine versus tenofovir/emtricitabine in virologically suppressed patients switching from ritonavir-boosted protease inhibitors to raltegravir.
AIDS research and human retroviruses 2013;29(2):235-41.
2013: Pedro Castro; Teresa Gallart; José M Bayas; José M Gatell; Raquel González; Anna López; Jose M Nicolas; Montserrat Plana; Tomàs Pumarola; Anna Vilella; Felipe García
Influence of episodes of intermittent viremia ("blips") on immune responses and viral load rebound in successfully treated HIV-infected patients.
AIDS research and human retroviruses 2013;29(1):68-76.
2012: Esteban Martínez; Xabier Moreno; Ignacio Perez; Judit Pich; Daniel Podzamczer; Antonio Antela; Juan Berenguer; Polyana M D'Albuquerque; Pere Domingo; José M Gatell; Felix Gutierrez; Josep M Llibre
Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir.
AIDS (London, England) 2012;26(18):2315-26.
2012: Víctor Casanova; Nuria Climent; Rafael Franco; Teresa Gallart; Felipe García; José M Gatell; Carme Lluis; Josefa Mallol; Marta Massanella; Isaac Naval-Macabuhay; Marta Rodríguez-García; Julià Blanco; Peter J McCormick
Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals.
PloS one 2012;7(12):e51287.
2012: Lander Egaña-Gorroño; Tuixent Escribà; José M Gatell; Esteban Martínez; Marta Calvo; Mireia Arnedo
Association study of lipoprotein(a) genetic markers, traditional risk factors, and coronary heart disease in HIV-1-infected patients.
Frontiers in immunology 2012;3():367.
2011: José M Miró; Tomas Pumarola; Laura Zamora; Teresa Gallart; Zoe Herreras; Christian Manzardo; José M Gatell
[Clinical management of acute and chronic human immunodeficiency virus infection before starting antiretroviral treatment].
Enfermedades infecciosas y microbiología clínica 2011;29(10):759-72.
2011: José M Gatell
Antiretroviral therapy for HIV: do subtypes matter?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;53(11):1153-5.
2011: Carmen Elena Gómez; Rubén González-Sanz; Alberto C Guardo; José Luis Jiménez; Victoria Jiménez; Juan Carlos López Bernaldo De Quirós; María Angeles Muñoz-Fernández; José Luis Nájera; Beatriz Perdiguero; Montserrat Plana; Carlos Oscar S Sorzano; Felipe García; Juan García-Arriaza; José M Gatell; Mariano Esteban
The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens.
Journal of virology 2011;85(21):11468-78.
2011: Felipe García; Juan García-Arriaza; José M Gatell; Carmen Elena Gómez; Nuria González; Alberto C Guardo; José Luis Jiménez; Victoria Jiménez; Agathe León; Peter Liljeström; María J Maleno; María Angeles Muñoz-Fernández; José Luis Nájera; Giuseppe Pantaleo; Beatriz Perdiguero; Iñaki Pérez; Judit Pich; Montserrat Plana; Jonathan Weber; José Alcamí; Amparo Alvarez; Joan Albert Arnaiz; Juan Carlos López Bernaldo de Quirós; Matilde Sánchez Conde; Vicens Díaz-Brito; Mariano Esteban
Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02).
Vaccine 2011;29(46):8309-16.
2011: Carlos Cervera; Ana del Río; Carlos Falces; Laura García; José M Gatell; Francesc Marco; Carlos A Mestres; José M Miró; Asunción Moreno; Marga Robau; Marta Sala; Manel Almela
Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study.
Enfermedades infecciosas y microbiología clínica 2011;29(8):587-92.
2011: Cristina Gil; Carmen Hurtado; Agathe León; Jeffrey D Lifson; Javier Martinez-Picado; L Miralles; José M Miró; Sara Nieto-Márquez; Tomás Pumarola; Cristina Rovira; Laura Zamora; Manel Almela; Christian Brander; Nuria Climent; Bonaventura Clotet; Judith Dalmau; Teresa Gallart; Felipe García; M Teresa García; José M Gatell
Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines.
Vaccine 2011;29(34):5711-24.
2011: M Medina-Ramírez; V Sánchez-Merino; Sonsoles Sánchez-Palomino; A Merino-Mansilla; C B Ferreira; I Pérez; N González; A Alvarez; J M Alcocer-González; F García; José M Gatell; J Alcamí; E Yuste
Broadly cross-neutralizing antibodies in HIV-1 patients with undetectable viremia.
Journal of virology 2011;85(12):5804-13.
2011: Cristina Gil; M Teresa Garcia; Felipe Garcia; José M Miró; Fernando Agüero; Lucía Alós; Laura Zamora; Alicia Capón; Josep Costa; Tomás Pumarola; José M Gatell
Evaluation of the Roche COBAS® TaqMan® HIV-1 test for quantifying HIV-1 RNA in infected cells and lymphoid tissue.
Journal of virological methods 2011;174(1-2):69-76.
2011: Marylène Lejeune; José M Miró; Elisa De Lazzari; Felipe García; Xavier Claramonte; Esteban Martínez; Esteban Ribera; Julio Arrizabalaga; José R Arribas; Pere Domingo; Elena Ferrer; Montserrat Plana; María-Eugenia Valls; Daniel Podzamczer; Tomás Pumarola; Alain Jacquet; Josep Mallolas; José M Gatell; Teresa Gallart
Restoration of T cell responses to toxoplasma gondii after successful combined antiretroviral therapy in patients with AIDS with previous toxoplasmic encephalitis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52(5):662-70.
2011: M Florencia Etcheverry; Paula J Lum; Jennifer L Evans; Emilia Sanchez; Elisa de Lazzari; Eva Mendez-Arancibia; Ernesto Sierra; José M Gatell; Kimberly Page; Joan Joseph
HIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco.
Vaccine 2011;29(10):1991-6.
2011: José M Martinez-Navio; Víctor Casanova; Rodrigo Pacheco; Isaac Naval-Macabuhay; Nuria Climent; Felipe Garcia; José M Gatell; Josefa Mallol; Teresa Gallart; Carmen Lluis; Rafael Franco
Adenosine deaminase potentiates the generation of effector, memory, and regulatory CD4+ T cells.
Journal of leukocyte biology 2011;89(1):127-36.
2010: Míriam J Alvarez-Martínez; José M Miró; Maria Eugenia Valls; Jordi Mas; Jorge Puig de la Bellacasa; Omar Sued; Manel Solé; Paula V Rivas; Elisa de Lazzari; Natividad Benito; Felipe García; Carlos Agustí; Paul E Wilson; José M Gatell; Maria Teresa Jiménez de Anta; Steven R Meshnick; Asunción Moreno
Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients.
Diagnostic microbiology and infectious disease 2010;68(1):60-5.
2010: María Teresa Martín; Montserrat Rovira; M Massanes; E del Cacho; E Carcelero; Montserrat Tuset; Carles Codina; J M Miro; José M Gatell; Josep Ribas
[Analysis of the duration of and reasons for changing the first combination of antiretroviral therapy].
Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria 2010;34(5):224-30.
2010: Elena Herrera; Solveig Tenckhoff; María J Gómara; Ramona Galatola; María J Bleda; Cristina Gil; Guadalupe Ercilla; José M Gatell; Hans L Tillmann; Isabel Haro
Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.
Journal of medicinal chemistry 2010;53(16):6054-63.
2010: Susana Guerra; José Manuel González; Núria Climent; Hugh Reyburn; Luis Andres Lopez-Fernandez; José L Nájera; Carmen E Gómez; Felipe García; José M Gatell; Teresa Gallart; Mariano Esteban
Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDS.
Journal of virology 2010;84(16):8141-52.
2010: Melanie A Thompson; Judith A Aberg; Pedro Cahn; Julio S G Montaner; Giuliano Rizzardini; Amalio Telenti; José M Gatell; Huldrych F Günthard; Scott M Hammer; Martin S Hirsch; Donna M Jacobsen; Peter Reiss; Douglas D Richman; Paul A Volberding; Patrick Yeni; Robert T Schooley
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.
JAMA : the journal of the American Medical Association 2010;304(3):321-33.
2010: Esteban Martínez; María Larrousse; Josep M Llibre; Félix Gutiérrez; Maria Saumoy; Antonio Antela; Hernando Knobel; Javier Murillas; Juan Berenguer; Judit Pich; Ignacio Pérez; José M Gatell
Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study.
AIDS (London, England) 2010;24(11):1697-707.
2010: José M Miró; Christian Manzardo; Judith Pich; Pere Domingo; Elena Ferrer; José R Arribas; Esteban Ribera; Julio Arrizabalaga; Montserrat Loncá; Anna Cruceta; Elisa de Lazzari; montserrat fuster; Daniel Podzamczer; Montserrat Plana; José M Gatell
Immune reconstitution in severely immunosuppressed antiretroviral-naive HIV type 1-infected patients using a nonnucleoside reverse transcriptase inhibitor-based or a boosted protease inhibitor-based antiretroviral regimen: three-year results (The Advanz Trial): a randomized, controlled trial.
AIDS research and human retroviruses 2010;26(7):747-57.
2010: C García-de-la-Mària; F Marco; Y Armero; Dolors Soy; A Moreno; A del Río; Manel Almela; C Cervera; S Ninot; C Falces; Carlos A Mestres; José M Gatell; M Teresa Jiménez de Anta; José M Miró
Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis.
Antimicrobial agents and chemotherapy 2010;54(7):2781-6.
2010: Esteban Martínez; María Larrousse; Daniel Podzamczer; Ignacio Pérez; Félix Gutiérrez; Montserrat Loncá; Patricia Barragán; Ramon Deulofeu; Roser Casamitjana; Josep Mallolas; Judit Pich; José M Gatell
Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction.
AIDS (London, England) 2010;24(3):F1-9.
2010: Marta Rodríguez-García; Núria Climent; Harold Oliva; Víctor Casanova; Rafael Franco; Agathe Leon; José M Gatell; Felipe García; Teresa Gallart
Increased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progression.
PloS one 2010;5(2):e9436.
2009: Pedro Castro; Montserrat Plana; Raquel González; Anna López; Anna Vilella; Roger Argelich; Teresa Gallart; Tomàs Pumarola; José M Bayas; José M Gatell; Felipe García
Influence of a vaccination schedule on viral load rebound and immune responses in successfully treated HIV-infected patients.
AIDS research and human retroviruses 2009;25(12):1249-59.
2009: José M Martinez-Navio; Nuria Climent; Rodrigo Pacheco; Felipe Garcia; Montserrat Plana; Meritxell Nomdedeu; Harold Oliva; Cristina Rovira; L Miralles; José M Gatell; Teresa Gallart; Josefa Mallol; Carme Lluis; Rafael Franco
Immunological dysfunction in HIV-1-infected individuals caused by impairment of adenosine deaminase-induced costimulation of T-cell activation.
Immunology 2009;128(3):393-404.
2009: Núria Climent; José M Martinez-Navio; Cristina Gil; Felipe Garcia; Cristina Rovira; Carmen Hurtado; Laia Miralles; José M Gatell; Teresa Gallart; Josefa Mallol; Carme Lluis; Rafael Franco
Adenosine deaminase enhances T-cell response elicited by dendritic cells loaded with inactivated HIV.
Immunology and cell biology 2009;87(8):634-9.
2009: Anna López; Nils van der Lubbe; Sonsoles Sánchez-Palomino; Mireia Arnedo; Meritxell Nomdedeu; Pedro Castro; Meritxell Guilà; Maria J Maleno; Felipe García; Teresa Gallart; José M Gatell; Montserrat Plana
Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine.
Vaccine 2009;27(44):6166-78.
2009: José M Miró; C García-de-la-Mària; Y Armero; Dolors Soy; Asunción Moreno; A del Río; Manel Almela; María Sarasa; Carlos A Mestres; José M Gatell; M Teresa Jiménez de Anta; Francesc Marco
Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2009;53(10):4172-7.
2009: Esteban Martínez; José A Arranz; Daniel Podzamczer; Montserrat Loncá; José Sanz; Patricia Barragán; Esteban Ribera; Hernando Knobel; Victor Roca; Félix Gutiérrez; José L Blanco; Josep Mallolas; Josep M Llibre; Bonaventura Clotet; David Dalmau; Ferran Segura; José R Arribas; Jaime Cosín; Pilar Barrufet; Esperanza Casas; Elena Ferrer; Adrià Curran; Alicia González; Judit Pich; Ana Cruceta; Joan A Arnaiz; José M Miró; José M Gatell
A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression.
Journal of acquired immune deficiency syndromes (1999) 2009;51(3):290-7.
2009: Marta Rodríguez-García; Harold Oliva; Nuria Climent; Maria M Escribese; Felipe García; Thomas M Moran; José M Gatell; Teresa Gallart
Impact of alpha-defensins1-3 on the maturation and differentiation of human monocyte-derived DCs. Concentration-dependent opposite dual effects.
Clinical immunology (Orlando, Fla.) 2009;131(3):374-84.
2009: Josep Mallolas; Daniel Podzamczer; Ana Milinkovic; Pere Domingo; Bonaventura Clotet; Esteve Ribera; Félix Gutiérrez; Hernando Knobel; Jaime Cosin; Elena Ferrer; José Alberto Arranz; Victor Roca; Francesc Vidal; Javier Murillas; Judit Pich; Enric Pedrol; Josep M Llibre; David Dalmau; Isabel García; Miquel Aranda; Ana Cruceta; Esteban Martínez; José L Blanco; Elisa de Lazzari; José M Gatell
Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study.
Journal of acquired immune deficiency syndromes (1999) 2009;51(1):29-36.
2009: Esteban Martínez; María Larrousse; José M Gatell
Cardiovascular disease and HIV infection: host, virus, or drugs?
Current opinion in infectious diseases 2009;22(1):28-34.
2008: José M Gatell; Laura Zamora
[Secondary effects associated with raltegravir].
Enfermedades infecciosas y microbiología clínica 2008;26 Suppl 12():34-9.
2008: José M Gatell
[Efficacy of raltegravir: from healthy volunteers to phase III trials].
Enfermedades infecciosas y microbiología clínica 2008;26 Suppl 12():29-33.
2008: José M Gatell
[Raltegravir: the first HIV integrase inhibitor. Introduction].
Enfermedades infecciosas y microbiología clínica 2008;26 Suppl 12():1-2.
2008: M Martin; E Del Cacho; Carles Codina; Montserrat Tuset; Elisa De Lazzari; Josep Mallolas; José M Miró; José M Gatell; Josep Ribas
Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study.
AIDS research and human retroviruses 2008;24(10):1263-8.
2008: Míriam J Alvarez-Martínez; Asunción Moreno; José M Miró; Maria Eugenia Valls; Paula V Rivas; Elisa de Lazzari; Omar Sued; Natividad Benito; Pere Domingo; Esteban Ribera; Miguel Santín; Guillermo Sirera; Ferràn Segura; Francesc Vidal; Francisco Rodríguez; Melchor Riera; Maria Elisa Cordero; José Ramón Arribas; Maria Teresa Jiménez de Anta; José M Gatell; Paul E Wilson; Steven R Meshnick
Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality.
Diagnostic microbiology and infectious disease 2008;62(1):34-43.
2008: Francesc Marco; Cristina García de la Mària; Yolanda Armero; Eurídice Amat; Dolors Soy; Asunción Moreno; Ana del Río; Manel Almela; Carlos A Mestres; José M Gatell; M Teresa Jiménez de Anta; José M Miró
Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2008;52(7):2538-43.
2008: Amanda Mocroft; Ole Kirk; P Aldins; A Chies; Anders Blaxhult; N Chentsova; N Vetter; François Dabis; José M Gatell; Jens D Lundgren
Loss to follow-up in an international, multicentre observational study.
HIV medicine 2008;9(5):261-9.
2008: Luis Martí; Carlos Cervera; Xavier Filella; José Luis Marín; Manel Almela; José M Gatell; Asunción Moreno
[Inflammatory response in elderly patients with bacteremia].
Enfermedades infecciosas y microbiología clínica 2008;26(3):146-9.
2008: Angeles Jaén; Anna Esteve; Josep M Miró; Cristina Tural; Alexandra Montoliu; Elena Ferrer; Melcior Riera; Ferran Segura; Lluís Force; Omar Sued; Josep Vilaró; Isabel Garcia; Angels Masabeu; Jordi Altès; Bonaventura Coltet; Daniel Podzamczer; Javier Murillas; Gemma Navarro; José M Gatell; Jordi Casabona
Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain).
Journal of acquired immune deficiency syndromes (1999) 2008;47(2):212-20.
2008: Josep Mallolas; Judith Pich; María Peñaranda; Pere Domingo; Hernando Knobel; Enric Pedrol; Félix Gutiérrez; Pilar Barrufet; Joaquim Peraire; Miguel A Asenjo; Francesc Vidal; José M Gatell
Induction therapy with trizivir plus efavirenz or lopinavir/ritonavir followed by trizivir alone in naive HIV-1-infected adults.
AIDS (London, England) 2008;22(3):377-84.
2007: María Larrousse; Montserrat Laguno; Marta Segarra; Elisa De Lazzari; Esteban Martinez; José L Blanco; Agathe León; Ramon Deulofeu; Rosa Miquel; Ana Milinkovic; Montserrat Lonca; José M Miró; Alejandra Biglia; Javier Murillas; José M Gatell; Josep Mallolas
Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients.
Journal of acquired immune deficiency syndromes (1999) 2007;46(3):304-11.
2007: Marta Garrido; Anna Mozos; Antonio Martínez; Felipe García; Anna Serafín; Vanesa Morente; Miguel Caballero; Cristina Gil; Emilio Fumero; José M Miró; Nuria Climent; José M Gatell; Llucia Alos
HIV-1 upregulates intercellular adhesion molecule-1 gene expression in lymphoid tissue of patients with chronic HIV-1 infection.
Journal of acquired immune deficiency syndromes (1999) 2007;46(3):268-74.
2007: Marta Rodríguez-García; Harold Oliva; Nuria Climent; Felipe García; José M Gatell; Teresa Gallart
Human immature monocyte-derived dendritic cells produce and secrete alpha-defensins 1-3.
Journal of leukocyte biology 2007;82(5):1143-6.
2007: Anna Suy; Pedro Castro; Meritxell Nomdedeu; Felipe García; Anna López; Emilio Fumero; Teresa Gallart; Lucia Lopalco; Oriol Coll; José M Gatell; Montserrat Plana
Immunological profile of heterosexual highly HIV-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activation.
The Journal of infectious diseases 2007;196(8):1191-201.
2007: Francesca Ceccherini-Silberstein; Alessandro Cozzi-Lepri; Lidia Ruiz; Amanda Mocroft; Andrew N Phillips; Christian Holkmann Olsen; José M Gatell; Huldrych F Gunthard; Peter Reiss; Carlo Federico Perno; Bonaventura Clotet; Jens D Lundgren
Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patients.
The Journal of infectious diseases 2007;196(8):1180-90.
2007: Josep Mallolas; José L Blanco; J Pich; Juan A Arnaiz; J M Peña; David Dalmau; Elisa De Lazzari; A Ochoa; Francesc Vidal; M A Ribas; Ferran Segura; Enric Pedrol; J Flores; Anna Cruceta; S Varea; José M Miró; Esteban Martínez; José M Gatell
A randomized trial comparing the efficacy and tolerability of two HAART strategies at two years in antiretroviral naive patients.
Revista clínica española 2007;207(9):427-32.
2007: Elena Ferrer; Jordi Niubo; Manel Crespo; José M Gatell; Jose Sanz; Sergio Veloso; Josep M Llibre; Pilar Barrufet; Pochita Sanchez; Daniel Podzamczer
Genotypic resistance in HIV-infected naive patients receiving abacavir plus lamivudine and efavirenz.
Journal of acquired immune deficiency syndromes (1999) 2007;46(2):253-5.
2007: Manuel Ramos-Casals; Xavier Forns; Pilar Brito-Zerón; A Vargas; M Ruiz; Montserrat Laguno; Jordi Yagüe; José M Sánchez-Tapias; José M Gatell; Josep Font
Cryoglobulinaemia associated with hepatitis C virus: influence of HCV genotypes, HCV-RNA viraemia and HIV coinfection.
Journal of viral hepatitis 2007;14(10):736-42.
2007: Agathe León; Esteban Martinez; María Sarasa; Yamilé López; Josep Mallolas; Elisa De Lazzari; Montserrat Laguno; A Milincovic; José L Blanco; María Larrousse; Montserrat Lonca; José M Gatell
Impact of steady-state lopinavir plasma levels on plasma lipids and body composition after 24 weeks of lopinavir/ritonavir-containing therapy free of thymidine analogues.
The Journal of antimicrobial chemotherapy 2007;60(4):824-30.
2007: Miquel Bruguera; Miquel Torres; Magda Campins; Jose-Maria Bayas; Andreu Segura; José Luis Barrio; Rafael Esteban; José M Gatell; Magda Martínez; Joan Monés; Angel Plans; Ramon Planas; Consol Serra; Cristina Tural; Joan Villalbi
[Risk of transmission of HIV or hepatitis B or C viruses from an infected physician. Preventive measures].
Medicina clínica 2007;129(8):309-13.
2007: Joaquim Peraire; Oscar Miró; Maria Saumoy; Pere Domingo; Enric Pedrol; Francesc Villarroya; Esteban Martínez; Miguel López-Dupla; Glòria Garrabou; Maria Antonia Sambeat; Elisabet Deig; Joan Villarroya; Matilde R Chacón; Sònia López; Angels Fontanet; Maija Holmstrom; Marta Giralt; José M Gatell; Francesc Vidal
HIV-1-infected long-term non-progressors have milder mitochondrial impairment and lower mitochondrially-driven apoptosis in peripheral blood mononuclear cells than typical progressors.
Current HIV research 2007;5(5):467-73.
2007: Eung-Jun Im; Narcis Saubi; Goretti Virgili; Clare Sander; Denise Teoh; José M Gatell; Helen McShane; Joan Joseph; Tomás Hanke
Vaccine platform for prevention of tuberculosis and mother-to-child transmission of human immunodeficiency virus type 1 through breastfeeding.
Journal of virology 2007;81(17):9408-18.
2007: Esteban Martínez; José M Gatell
Considerations on the effectiveness of nevirapine in protease inhibitor-based regimen simplification.
AIDS (London, England) 2007;21(13):1829-30.
2007: Amanda Mocroft; Andrew N Phillips; José M Gatell; bruno ledergerber; Martin Fisher; Nathan Clumeck; Marcelo H Losso; Adriano Lazzarin; G Fatkenheuer; Jens D Lundgren
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study.
Lancet 2007;370(9585):407-13.
2007: Juan P Horcajada; Laura García; Natividad Benito; Carlos Cervera; Marta Sala; Angels Olivera; Alex Soriano; Marga Robau; José M Gatell; José M Miró
[Specialized home care for infectious disease. Experience from 1995 to 2002].
Enfermedades infecciosas y microbiología clínica 2007;25(7):429-36.
2007: Susana Guerra; José Luis Nájera; José Manuel González; Luis Andres Lopez-Fernandez; Nuria Climent; José M Gatell; Teresa Gallart; Mariano Esteban
Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC.
Journal of virology 2007;81(16):8707-21.
2007: Pedro Castro; Montserrat Laguno; Meritxell Nomdedeu; Anna López; Montserrat Plana; Emilio Fumero; Teresa Gallart; Josep Mallolas; José M Gatell; Felipe García
Clinicoimmunological progression and response to treatment of long-term nonprogressor HIV-hepatitis C virus-coinfected patients.
AIDS research and human retroviruses 2007;23(7):863-7.
2007: Mar Naranjo-Gómez; Harold Oliva; Nuria Climent; Marco A Fernández; Marta Ruiz-Riol; Margarita Bofill; José M Gatell; Teresa Gallart; Ricardo Pujol Borrell; Francesc E Borras
Expression and function of the IL-2 receptor in activated human plasmacytoid dendritic cells.
European journal of immunology 2007;37(7):1764-72.
2007: José M Miró; Cristina García-de-la-Mària; Yolanda Armero; Elisa De Lazzari; Dolors Soy; Asunción Moreno; Ana del Rio; Manel Almela; Carlos A Mestres; José M Gatell; M Teresa Jiménez de Anta; Francesc Marco
Efficacy of telavancin in the treatment of experimental endocarditis due to glycopeptide-intermediate Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2007;51(7):2373-7.
2007: María Teresa Martín; Elena del Cacho; Ester López; Carles Codina; Montserrat Tuset; Elisa De Lazzari; José M Miró; José M Gatell; Josep Ribas
[Adverse side effects of antiretroviral therapy: relationship between patients' perception and adherence].
Medicina clínica 2007;129(4):127-33.
2007: José M Gatell; Dominique Salmon-Ceron; Adriano Lazzarin; Eric Van Wijngaerden; Francisco Antunes; Clifford Leen; Andrzej Horban; Victoria Wirtz; Linda Odeshoo; Monique Van den Dungen; Claudia Gruber; Emilio Ledesma
Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(11):1484-92.
2007: Amanda Mocroft; Ole Kirk; José M Gatell; Peter Reiss; Panagiotis Gargalianos; Kai Zilmer; Marek Beniowski; Jean-Paul Viard; Schlomo Staszewski; Jens D Lundgren
Chronic renal failure among HIV-1-infected patients.
AIDS (London, England) 2007;21(9):1119-27.
2007: Esteban Martínez; Ana Milinkovic; E Buira; Elisa De Lazzari; Agathe León; María Larrousse; Montserrat Loncá; Montserrat Laguno; José L Blanco; Josep Mallolas; Felipe García; José M Miró; José M Gatell
Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
HIV medicine 2007;8(4):251-8.
2007: Josep Mallolas; Jl Blanco; Pablo Labarga; Antonio Vergara; Antonio Ocampo; María Sarasa; Mireia Arnedo; Y López-Púa; J García; J Juega; Ana Guelar; Alberto Terrón; David Dalmau; I García; M Zárraga; Esteban Martínez; Xavier Carné; Tomás Pumarola; R Escayola; José M Gatell
Inhibitory quotient as a prognostic factor of response to a salvage antiretroviral therapy containing ritonavir-boosted saquinavir. The CIVSA Study.
HIV medicine 2007;8(4):226-33.
2007: Joaquim Peraire; Francesc Vidal; Montserrat Plana; Pere Domingo; Blai Coll; Consuelo Viladés; Felipe Garcia; Sergi Veloso; José M Gatell; Montserrat Broch
Polymorphisms in the 3' untranslated region of the fractalkine (CX3CL1) gene and the risk of HIV-1 infection and disease progression.
AIDS (London, England) 2007;21(7):891-3.
2007: Beatriz Grinsztejn; Bach-Yen Nguyen; Christine Katlama; José M Gatell; Adriano Lazzarin; Daniel Vittecoq; Charles J Gonzalez; Joshua Chen; Charlotte M Harvey; Robin D Isaacs
Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial.
Lancet 2007;369(9569):1261-9.
2007: Andrew Hill; Kiat Ruxrungtham; Mattana Hanvanich; Christine Katlama; Eva Wolf; Vincent Soriano; Ana Milinkovic; José M Gatell; Esteban Ribera
Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment.
Expert opinion on pharmacotherapy 2007;8(5):679-88.
2007: Araceli Rousaud; Jordi Blanch; Martin Hautzinger; Elisa De Lazzari; Josep-Maria Peri; Olga Puig; Esteban Martinez; Guillem Masana; Joan de Pablo; José M Gatell
Improvement of psychosocial adjustment to HIV-1 infection through a cognitive-behavioral oriented group psychotherapy program: a pilot study.
AIDS patient care and STDs 2007;21(3):212-22.
2007: Josep Mallolas; María Sarasa; Meritxell Nomdedeu; Alex Soriano; Y López-Púa; José L Blanco; Esteban Martínez; José M Gatell
Pharmacokinetic interaction between rifampicin and ritonavir-boosted atazanavir in HIV-infected patients.
HIV medicine 2007;8(2):131-4.
2007: Agnès Libois; Stéphane De Wit; Bénédicte Poll; Felipe Garcia; Eric Florence; Ana Del Rio; Paquita Sanchez; Eugenia Negredo; Marc Vandenbruaene; José M Gatell; Nathan Clumeck
HIV and syphilis: when to perform a lumbar puncture.
Sexually transmitted diseases 2007;34(3):141-4.
2007: Christine Katlama; Roberto Esposito; José M Gatell; Jean-Christophe Goffard; Beatriz Grinsztejn; Anton Pozniak; Jürgen Rockstroh; Albrecht Stoehr; Norbert Vetter; Patrick Yeni; Wim Parys; Tony Vangeneugden
Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1.
AIDS (London, England) 2007;21(4):395-402.
2007: Montserrat Laguno; María Larrousse; Javier Murillas; José L Blanco; Agathe León; Ana Milinkovic; Montserrat Loncá; Esteban Martinez; José M Sánchez-Tapias; Elisa De Lazzari; José M Gatell; Josep Costa; Josep Mallolas
Predictive value of early virologic response in HIV/hepatitis C virus-coinfected patients treated with an interferon-based regimen plus ribavirin.
Journal of acquired immune deficiency syndromes (1999) 2007;44(2):174-8.
2007: Daniel Podzamczer; Elena Ferrer; Pochita Sanchez; José M Gatell; Manel Crespo; Cesar Fisac; Montserrat Lonca; Jose Sanz; Jordi Niubo; Sergio Veloso; Josep M Llibre; Pilar Barrufet; María A Ribas; Esperanza Merino; Esteban Ribera; Javier Martínez-Lacasa; Carlos Alonso; Miquel Aranda; Federico Pulido; Juan Berenguer; Antonio Delegido; José Pedreira; Ana Lérida; Rafael Rubio; Luis del Río
Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized study.
Journal of acquired immune deficiency syndromes (1999) 2007;44(2):139-47.
2007: Consuelo Viladés; Montserrat Broch; Montserrat Plana; Pere Domingo; Carlos Alonso-Villaverde; Enric Pedrol; Hernando Knobel; David Dalmau; Joaquim Peraire; Cristina Gutiérrez; Anna López; Maria Antonia Sambeat; Montserrat Olona; Felipe Garcia; Cristóbal Richart; José M Gatell; Francesc Vidal
Effect of genetic variants of CCR2 and CCL2 on the natural history of HIV-1 infection: CCL2-2518GG is overrepresented in a cohort of Spanish HIV-1-infected subjects.
Journal of acquired immune deficiency syndromes (1999) 2007;44(2):132-8.
2007: Esteban Martínez; Juan A Arnaiz; Daniel Podzamczer; David Dalmau; Esteban Ribera; Pere Domingo; Hernando Knobel; María Leyes; Enric Pedrol; Lluís Force; Elisa De Lazzari; José M Gatell
Three-year follow-up of protease inhibitor-based regimen simplification in HIV-infected patients.
AIDS (London, England) 2007;21(3):367-9.
2007: Ana Milinkovic; Esteban Martinez; Sònia López; Elisa De Lazzari; Oscar Miró; Sergi Vidal; José L Blanco; Glòria Garrabou; Montserrat Laguno; Juan A Arnaiz; Agathe Leon; María Larrousse; Montserrat Lonca; Josep Mallolas; José M Gatell
The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients.
Antiviral therapy 2007;12(3):407-15.
2007: Amanda Mocroft; Schlomo Staszewski; Rainer Weber; José M Gatell; Jürgen Rockstroh; Jacek Gasiorowski; George Panos; Antonella d'Arminio Monforte; Aza Rakhmanova; Andrew N Phillips; Jens D Lundgren
Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts.
Antiviral therapy 2007;12(3):325-33.
2007: Brendan Larder; Dechao Wang; Andrew Revell; Julio Montaner; Richard Harrigan; Frank De Wolf; Joep Lange; Scott Wegner; Lidia Ruiz; María Jesús Pérez-Elías; Sean Emery; José M Gatell; Antonella d'Arminio Monforte; Carlo Torti; Maurizio Zazzi; Clifford Lane
The development of artificial neural networks to predict virological response to combination HIV therapy.
Antiviral therapy 2007;12(1):15-24.
2006: Joan Joseph; Narcis Saubi; Elías Pezzat; José M Gatell
Progress towards an HIV vaccine based on recombinant bacillus Calmette-Guérin: failures and challenges.
Expert review of vaccines 2006;5(6):827-38.
2006: Mar Naranjo-Gómez; Nuria Climent; Joan Cos; Harold Oliva; Margarita Bofill; José M Gatell; Teresa Gallart; Ricardo Pujol Borrell; Francesc E Borras
Tacrolimus treatment of plasmacytoid dendritic cells inhibits dinucleotide (CpG-)-induced tumour necrosis factor-alpha secretion.
Immunology 2006;119(4):488-98.
2006: Rodrigo Pacheco; Harold Oliva; José M Martinez-Navío; Nuria Climent; Francisco Ciruela; José M Gatell; Teresa Gallart; Josefa Mallol; Carmen Lluis; Rafael Franco
Glutamate released by dendritic cells as a novel modulator of T cell activation.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(10):6695-704.
2006: Míriam J Alvarez-Martínez; José M Miró; Maria Eugenia Valls; Asunción Moreno; Paula V Rivas; Manel Solé; Natividad Benito; Pere Domingo; Carmen Muñoz; Esteban Rivera; Heather J Zar; Gustavo Wissmann; Ada R S Diehl; João Carlos Prolla; Maria Teresa Jiménez de Anta; José M Gatell; Paul E Wilson; Steven R Meshnick
Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens.
Diagnostic microbiology and infectious disease 2006;56(2):153-60.
2006: José L Blanco; Alejandra Biglia; Elisa De Lazzari; Josep Mallolas; Esteban Martinez; Tomás Pumarola; María Larrousse; Ana Milinkovic; Agathe León; Montserrat Lonca; Montserrat Laguno; José M Gatell
Antiretroviral activity of didanosine in patients with different clusters of reverse transcriptase mutations.
AIDS (London, England) 2006;20(14):1891-2.
2006: Cesar Caceres; Enrique J Gomez; Felipe Garcia; José M Gatell; Francisco Del Pozo
An integral care telemedicine system for HIV/AIDS patients.
International journal of medical informatics 2006;75(9):638-42.
2006: Josep Mallolas; José M Gatell; Miquel Bruguera
Transmission of HIV-1 from an obstetrician to a patient during a caesarean section.
AIDS (London, England) 2006;20(13):1785.
2006: Scott M Hammer; Michael S Saag; Mauro Schechter; Julio S G Montaner; Robert T Schooley; Donna M Jacobsen; Melanie A Thompson; Charles C J Carpenter; Margaret A Fischl; Brian G Gazzard; José M Gatell; Martin S Hirsch; David A Katzenstein; Douglas D Richman; STEFANO VELLA; Patrick G Yeni; Paul A Volberding
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.
JAMA : the journal of the American Medical Association 2006;296(7):827-43.
2006: Scott M Hammer; Michael S Saag; Mauro Schechter; Julio S G Montaner; Robert T Schooley; Donna M Jacobsen; Melanie A Thompson; Charles C J Carpenter; Margaret A Fischl; Brian G Gazzard; José M Gatell; Martin S Hirsch; David A Katzenstein; Douglas D Richman; STEFANO VELLA; Patrick G Yeni; Paul A Volberding
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2006;14(3):827-43.
2006: Agnès Libois; Anna López; Felipe Garcia; Pedro Castro; María J Maleno; Ana García; Nuria Climent; Mireia Arnedo; Teresa Gallart; José M Gatell; Montserrat Plana
Dynamics of T cells subsets and lymphoproliferative responses during structured treatment interruption cycles and after definitive interruption of HAART in early chronic HIV type-1-infected patients.
AIDS research and human retroviruses 2006;22(7):657-66.
2006: Wendy P Bannister; Ole Kirk; José M Gatell; Brygida Knysz; Jean-Paul Viard; Helene Mens; Antonella d'Arminio Monforte; Andrew N Phillips; Amanda Mocroft; Jens D Lundgren
Regional changes over time in initial virologic response rates to combination antiretroviral therapy across Europe.
Journal of acquired immune deficiency syndromes (1999) 2006;42(2):229-37.
2006: Alan R Lifson; Frank S Rhame; Waldo H Belloso; Ulrik B Dragsted; Wafaa M El-Sadr; José M Gatell; Jennifer F Hoy; Eric A Krum; Ray Nelson; Court Pedersen; Sarah L Pett; Richard Davey
Reporting and evaluation of HIV-related clinical endpoints in two multicenter international clinical trials.
HIV clinical trials 2006;7(3):125-41.
2006: Josep M Sierra; Francesca Sánchez; Pedro Castro; Margarita Salvadó; Gloria de la Red; Agnes Libois; Manel Almela; Francesca March; Montserrat Español; Maria Antonia Sambeat; Joan Romeu; M Teresa Brugal; Patricia García De Olalla; José M Gatell; Jordi Vila; Felipe García; José L López-Colomés; Joan A Caylà; Pere Coll
Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003.
Medicine 2006;85(3):139-46.
2006: José L Blanco; Alejandra Biglia; E Martinez; M Sánchez; Elisa De Lazzari; Agathe Leon; Ana Milinkovic; María Larrousse; Montserrat Lonca; Montserrat Laguno; Josep Mallolas; José M Gatell
Intrathoracic fat in HIV-infected patients.
HIV medicine 2006;7(4):213-7.
2006: Omar Sued; José M Miró; Aitor Alquezar; Xavier Claramonte; Felipe García; Montserrat Plana; Mireia Arnedo; Elisa De Lazzari; Cristina Gil; Christian Manzardo; José L Blanco; Esteban Martínez; Josep Mallolas; Joan Joseph; Tomás Pumarola; Teresa Gallart; José M Gatell
Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003).
Enfermedades infecciosas y microbiología clínica 2006;24(4):238-44.
2006: J Gold; M J Batterham; H Rekers; M K Harms; T B P Geurts; P M E Helmyr; J Silva de Mendonça; L H Falleiros Carvalho; George Panos; A Pinchera; Fernando Aiuti; C Lee; Andrzej Horban; José M Gatell; Praphan Phanuphak; Wisit Prasithsirikul; B Gazzard; M Bloch; S A Danner
Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
HIV medicine 2006;7(3):146-55.
2006: Fiona C Lampe; José M Gatell; Schlomo Staszewski; Margaret A Johnson; Christian Pradier; M John Gill; Elisa de Lazzari; Brenda Dauer; Mike Youle; Eric Fontas; Hartmut B Krentz; Andrew N Phillips
Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002.
Archives of internal medicine 2006;166(5):521-8.
2006: Laura Gratacòs; Montserrat Tuset; Carles Codina; José M Miró; Josep Mallolas; Núria Miserachs; M Teresa Martín-Conde; Elena del Cacho; Elisa de Lazzari; Josep Ribas; José M Gatell
[Antiretroviral therapy of HIV infection: duration and reasons for changing the first therapeutic regimen in 518 patients].
Medicina clínica 2006;126(7):241-5.
2006: Glòria Garrabou; Eduard Sanjurjo; Oscar Miró; Esteban Martínez; Ana B Infante; Sònia López; Francesc Cardellach; José M Gatell; Jordi Casademont
Noninvasive diagnosis of mitochondrial dysfunction in HAART-related hyperlactatemia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(4):584-5.
2006: Esteban Martínez; Ana Milinkovic; Luis Bianchi; José M Gatell
Considerations about the value of sonography for the measurement of regional body fat.
AIDS (London, England) 2006;20(3):465-6.
2006: Juan Berenguer; María Jesús Pérez-Elías; José M Bellón; Hernando Knobel; Pablo Rivas-González; José M Gatell; Máximo Miguélez; José Hernández Quero; Juan Flores; Vicente Soriano; Ignacio Santos; Daniel Podzamczer; Monserrat Sala; Manuel Camba; Salvador Resino
Effectiveness and safety of abacavir, lamivudine, and zidovudine in antiretroviral therapy-naive HIV-infected patients: results from a large multicenter observational cohort.
Journal of acquired immune deficiency syndromes (1999) 2006;41(2):154-9.
2006: Josep Mallolas; Mireia Arnedo; Tomás Pumarola; Alejo Erice; José L Blanco; Esteban Martínez; José M Gatell
Transmission of HIV-1 from an obstetrician to a patient during a caesarean section.
AIDS (London, England) 2006;20(2):285-7.
2006: Oriol Coll; Anna Suy; Francesc Figueras; Valérie Vernaeve; Esteban Martínez; Daniel Mataró; Mercè Durban; Montserrat Lonca; Ricard Vidal; José M Gatell
Decreased pregnancy rate after in-vitro fertilization in HIV-infected women receiving HAART.
AIDS (London, England) 2006;20(1):121-3.
2006: Anna Suy; Esteban Martínez; Oriol Coll; Montserrat Lonca; Montse Palacio; Elisa De Lazzari; María Larrousse; Ana Milinkovic; Sandra Hernández; José L Blanco; Josep Mallolas; Agathe León; Juan A Vanrell; José M Gatell
Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy.
AIDS (London, England) 2006;20(1):59-66.
2005: Amanda Mocroft; Vincent Soriano; Jürgen Rockstroh; Peter Reiss; Ole Kirk; Stephane de Wit; José M Gatell; Bonaventura Clotet; Andrew N Phillips; Jens D Lundgren
Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?
AIDS (London, England) 2005;19(18):2117-25.
2005: Esteban Ribera; Carlos Azuaje; Rosa M Lopez; Pere Domingo; Alex Soriano; Leonor Pou; Paquita Sánchez; Josep Mallolas; Maria Antonia Sambea; Vicenç Falco; Imma Ocaña; Josep Lluis Lopez-Colomes; José M Gatell; Albert Pahissa
Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study).
Journal of acquired immune deficiency syndromes (1999) 2005;40(3):317-23.
2005: Agathe León; Josep Mallolas; Esteban Martinez; Elisa De Lazzari; Tomás Pumarola; María Larrousse; Ana Milincovic; Montserrat Lonca; José L Blanco; Montserrat Laguno; Alejandra Biglia; José M Gatell
High rate of virological failure in maintenance antiretroviral therapy with didanosine and tenofovir.
AIDS (London, England) 2005;19(15):1695-7.
2005: Alex Soriano; Francisco Lozano; Harold Oliva; Felipe García; Meritxell Nomdedéu; Elisa De Lazzari; Carmen Rodríguez; Alicia Barrasa; José I Lorenzo; Jorge del Romero; Montserrat Plana; José M Miró; José M Gatell; Jordi Vives; Teresa Gallart
Polymorphisms in the interleukin-4 receptor alpha chain gene influence susceptibility to HIV-1 infection and its progression to AIDS.
Immunogenetics 2005;57(9):644-54.
2005: M Arnedo-Valero; Felipe Garcia; Cristina Gil; T Guila; Emilio Fumero; Pedro Castro; José L Blanco; José M Miró; Tomás Pumarola; José M Gatell
Risk of selecting de novo drug-resistance mutations during structured treatment interruptions in patients with chronic HIV infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(6):883-90.
2005: Jochen Bäuerle; Rosa Miquel; Montserrat Laguno; Josep Mallolas; Javier Murillas; José M Gatell; Ulrich A Walker
Hepatic steatosis with stavudine in HIV/hepatitis C virus co-infection.
AIDS (London, England) 2005;19(13):1441-2.
2005: Anna Ochoa de Echagüen; Mireia Arnedo; Mariona Xercavins; Esteban Martinez; Beatriz Rosón; Esteban Ribera; Pere Domingo; Alicia González; Melcior Riera; Josep M Llibre; José M Gatell; David Dalmau
Genotypic and phenotypic resistance patterns at virological failure in a simplification trial with nevirapine, efavirenz or abacavir.
AIDS (London, England) 2005;19(13):1385-91.
2005: Oscar Miró; Sònia López; Joaquim Fernández-Solà; Glòria Garrabou; Enric Pedrol; Eva Badia; Esteban Martínez; Francesc Cardellach; José M Gatell; Jordi Casademont
Short communication: HIV infection, antiretrovirals, and apoptosis: studies on skeletal muscle.
AIDS research and human retroviruses 2005;21(8):702-5.
2005: Rodrigo Pacheco; J M Martinez-Navio; Marylène Lejeune; Nuria Climent; Harold Oliva; José M Gatell; Teresa Gallart; Josefa Mallol; Carmen Lluis; Rafael Franco
CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(27):9583-8.
2005: Cesar Fisac; Emilio Fumero; Manel Crespo; Beatriz Roson; Elena Ferrer; Nuria Virgili; Esteban Ribera; José M Gatell; Daniel Podzamczer
Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine.
AIDS (London, England) 2005;19(9):917-25.
2005: José L Blanco; M Alejandra Biglia; Mireia Arnedo; Esteban Martínez; Josep Mallolas; Ana Milinkovic; Montserrat Laguno; María Larrousse; Agathe Leon; Montserrat Lonca; Felipe García; José M Miró; Tomás Pumarola; José M Gatell
Evolution of resistance mutations pattern in HIV-1-infected patients during intensification therapy with a boosted protease inhibitor.
AIDS (London, England) 2005;19(8):829-31.
2005: Felipe García; Marylène Lejeune; Nuria Climent; Cristina Gil; José Alcamí; Vanesa Morente; Llucia Alós; Alba Ruiz; Javier Setoain; Emilio Fumero; Pedro Castro; Anna López; Anna Cruceta; Carlos Piera; Eric Florence; Arturo Pereira; Agnes Libois; Nuria González; Meritxell Guilá; Miguel Caballero; Francisco Lomeña; Joan Joseph; José M Miró; Tomás Pumarola; Montserrat Plana; José M Gatell; Teresa Gallart
Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection.
The Journal of infectious diseases 2005;191(10):1680-5.
2005: Angeles Jaén; Jordi Casabona; Anna Esteve; José M Miró; Cristina Tural; Elena Ferrer; Melcior Riera; Ferran Segura; Lluís Force; Omar Sued; Josep Vilaró; Angels Masabeu; Isabel García; Esther Dorca; Jordi Altès; Gemma Navarro; Daniel Podzamczer; Concepción Villalonga; Bonaventura Clotet; José M Gatell
[Clinical-epidemiological characteristics and antiretroviral treatment trends in a cohort of HIV infected patients. The PISCIS Project].
Medicina clínica 2005;124(14):525-31.
2005: Jochen Bäuerle; Montserrat Laguno; Stefan Mauss; Josep Mallolas; Javier Murillas; Rosa Miquel; Guenther Schmutz; Bernhard Setzer; José M Gatell; Ulrich A Walker
Mitochondrial DNA depletion in liver tissue of patients infected with hepatitis C virus: contributing effect of HIV infection?
HIV medicine 2005;6(2):135-9.
2005: Esperança Antón; Montserrat Sala; Josep Mallolas; Gemma Navarro; Manuel Cervantes; José M Gatell; Ferran Segura
[Clinical and epidemiological study of a series of HIV-infected patients over 50 years old].
Enfermedades infecciosas y microbiología clínica 2005;23(3):145-8.
2005: Christian Holkmann Olsen; José M Gatell; bruno ledergerber; Christine Katlama; Nina Friis-Møller; Jonathan Weber; Andrzej Horban; Schlomo Staszewski; Jens D Lundgren; Andrew N Phillips
Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen.
AIDS (London, England) 2005;19(3):319-30.
2005: Agathe León; Esteban Martinez; Josep Mallolas; Montserrat Laguno; José L Blanco; Tomás Pumarola; José M Gatell
Early virological failure in treatment-naive HIV-infected adults receiving didanosine and tenofovir plus efavirenz or nevirapine.
AIDS (London, England) 2005;19(2):213-5.
2005: Stefan Mauss; Ana Milinkovic; Christian Hoffmann; Stefanie Holm; Florian Berger; Esteban Martínez; Birger Kuhlmann; José M Gatell; Guenther Schmutz
Low rate of treatment failure on antiretroviral therapy with tenofovir, lamivudine and zidovudine.
AIDS (London, England) 2005;19(1):101-2.
2005: Oscar Miró; Joan Villarroya; Glòria Garrabou; Sònia López; M Luisa Rodríguez de la Concepción; Enric Pedrol; Esteban Martínez; Marta Giralt; José M Gatell; Francesc Cardellach; Jordi Casademont; Francesc Villarroya
In vivo effects of highly active antiretroviral therapies containing the protease inhibitor nelfinavir on mitochondrially driven apoptosis.
Antiviral therapy 2005;10(8):945-51.
2005: Cesar Caceres; Enrique J Gomez; Felipe Garcia; Paloma Chausa; Jorge Guzman; Francisco Del Pozo; José M Gatell
A Home Integral Telecare System for HIV/AIDS Patients.
Studies in health technology and informatics 2005;114():23-9.
2005: Montserrat Laguno; Ana Milinkovic; Elisa De Lazzari; Javier Murillas; Esteban Martínez; José L Blanco; Montserrat Loncá; Alejandra Biglia; Agathe Leon; Mercedes García; María Larrousse; Felipe García; José M Miró; José M Gatell; Josep Mallolas
Incidence and risk factors for mitochondrial toxicity in treated HIV/HCV-coinfected patients.
Antiviral therapy 2005;10(3):423-9.
2005: Olga Millán; Mercè Brunet; Jaume Martorell; Felipe García; Elena Vidal; Isabel Rojo; Montserrat Plana; Teresa Gallart; Tomás Pumarola; José M Miró; José M Gatell
Pharmacokinetics and pharmacodynamics of low dose mycophenolate mofetil in HIV-infected patients treated with abacavir, efavirenz and nelfinavir.
Clinical pharmacokinetics 2005;44(5):525-38.
2005: Daniel Podzamczer; Elena Ferrer; José M Gatell; Jordi Niubo; David Dalmau; Agathe Leon; Hernando Knobel; Carolina Polo; Daniel Iniguez; Isaac Ruiz
Early virological failure with a combination of tenofovir, didanosine and efavirenz.
Antiviral therapy 2005;10(1):171-7.
2005: Montserrat Laguno; José M Sánchez-Tapias; Javier Murillas; Xavier Forns; José L Blanco; Esteban Martínez; María Larrousse; Agathe León; Montserrat Loncá; Ana Milinkovic; José M Miró; Felipe García; José M Gatell; Josep Mallolas
[Advances in the diagnosis and treatment of hepatitis C virus infection in patients with and without HIV infection].
Enfermedades infecciosas y microbiología clínica 2005;23(1):32-40.
2005: Llúcia Alòs; Pilar Navarrete; Vanesa Morente; Felipe Garcia; Marta Garrido; Montserrat Plana; Anna Mozos; Anna López; Cristina Gil; Tomás Pumarola; Miguel Caballero; Jordi Blanch; Emilio Fumero; José M Miró; Teresa Gallart; José M Gatell; Elias Campo
Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistence.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(1):127-36.
2004: Oscar Miró; Sònia López; M Luisa Rodríguez de la Concepción; Esteban Martínez; Enric Pedrol; Glòria Garrabou; Marta Giralt; Francesc Cardellach; José M Gatell; Francesc Vilarroya; Jordi Casademont
Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine.
Journal of acquired immune deficiency syndromes (1999) 2004;37(5):1550-5.
2004: Xavier Badía; Daniel Podzamczer; Irene Moral; Montse Roset; Juan A Arnaiz; Montse Loncà; Arnaldo Casiró; Beatriz Rosón; José M Gatell
Health-related quality of life in HIV patients switching to twice-daily indinavir/ritonavir regimen or continuing with three-times-daily indinavir-based therapy.
Antiviral therapy 2004;9(6):979-85.
2004: Montserrat Laguno; Jordi Blanch; Javier Murillas; José L Blanco; Agathe León; Montserrat Lonca; María Larrousse; Alejandra Biglia; Esteban Martinez; Felipe García; José M Miró; Joan de Pablo; José M Gatell; Josep Mallolas
Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C.
Antiviral therapy 2004;9(6):905-9.
2004: José A Iribarren; Pablo Labarga; Rafael Rubio; Juan Berenguer; José M Miró; Antonio Antela; Juan González; Santiago Moreno; Julio Arrizabalaga; Lourdes Chamorro; Bonaventura Clotet; José M Gatell; José López Aldeguer; Esteban Martínez; Rosa Polo; Montserrat Tuset; Pompeyo E. Viciana; Juan Miguel Santamaría; José María Kindelán; Esteban Ribera; Ferran Segura
[Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)].
Enfermedades infecciosas y microbiología clínica 2004;22(10):564-642.
2004: Amanda Mocroft; José M Gatell; Peter Reiss; bruno ledergerber; Ole Kirk; STEFANO VELLA; Anders Blaxhult; Andrew N Phillips; Jens Lundgren
Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapy.
AIDS (London, England) 2004;18(17):2333-7.
2004: Alejandra Biglia; José L Blanco; Esteban Martínez; Pere Domingo; Roser Casamitjana; María Sambeat; Ana Milinkovic; Mercedes Garcia; Montserrat Laguno; Agathe Leon; María Larrousse; Montserrat Lonca; Josep Mallolas; José M Gatell
Gynecomastia among HIV-infected patients is associated with hypogonadism: a case-control study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(10):1514-9.
2004: Amanda Mocroft; Antonella d'Arminio Monforte; Ole Kirk; Margaret A Johnson; N Friis-Moller; D Banhegyi; Anders Blaxhult; F Mulcahy; José M Gatell; Jens D Lundgren
Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA study.
HIV medicine 2004;5(6):437-47.
2004: Esteban Martínez; Montserrat Tuset; Ana Milinkovic; José M Miró; José M Gatell
Management of dyslipidaemia in HIV-infected patients receiving antiretroviral therapy.
Antiviral therapy 2004;9(5):649-63.
2004: María-Jesús Jiménez-Expósito; G Torres; A Baraldés; Natividad Benito; F Marco; J C Paré; A Moreno; Xavier Claramonte; Carlos A Mestres; Manel Almela; C García de la María; N Pérez; W A Schell; G Ralph Corey; John R Perfect; M Teresa Jiménez de Anta; José M Gatell; José M Miró
Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(7):e70-3.
2004: Montserrat Laguno; Javier Murillas; José L Blanco; Esteban Martínez; Rosa Miquel; José M Sánchez-Tapias; Xavier Bargallo; Angeles García-Criado; Elisa De Lazzari; María Larrousse; Agathe León; Montserrat Loncá; Ana Milinkovic; José M Gatell; Josep Mallolas
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients.
AIDS (London, England) 2004;18(13):F27-36.
2004: Oscar Miró; Sònia López; Esteban Martínez; Enric Pedrol; Ana Milinkovic; Elisabet Deig; Glòria Garrabou; Jordi Casademont; José M Gatell; Francesc Cardellach
Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(5):710-6.
2004: Eric Florence; Felipe García; Montserrat Plana; Emilio Fumero; Pedro Castro; Anna Lopez; Anna Cruceta; Cristina Gil; Mireia Arnedo; José M Miró; Tomás Pumarola; Teresa Gallart; José M Gatell
Long-term clinical follow-up, without antiretroviral therapy, of patients with chronic HIV-1 infection with good virological response to structured treatment interruption.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(4):569-74.
2004: Kathleen Squires; Adriano Lazzarin; José M Gatell; William G Powderly; Vadim Pokrovskiy; Jean-François Delfraissy; Joseph Jemsek; Antonio Rivero; Willy Rozenbaum; Shannon Schrader; Michael Sension; Asda Vibhagool; Alexandra Thiry; Michael Giordano
Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV.
Journal of acquired immune deficiency syndromes (1999) 2004;36(5):1011-9.
2004: Eduardo Fernandez-Cruz; Santiago Moreno; J Navarro; Bonaventura Clotet; Emilio Bouza; JAVIER CARBONE; Jose Peña; J Pérez Molina; Daniel Podzamczer; R Rubio; Imma Ocaña; Federico Pulido; Pompeyo E. Viciana; J A Maradona; R Blazquez; C Barros; C Quereda; C Rodriguez-Sainz; Juana Gil; M L Abad; L Díaz; C Cantó; M A Muñoz; E Ferrer; Antoni Jou; Guillem Sirera; M Díaz; F Lopez; José M Gatell; J Gonzalez-Lahoz
Therapeutic immunization with an inactivated HIV-1 Immunogen plus antiretrovirals versus antiretroviral therapy alone in asymptomatic HIV-infected subjects.
Vaccine 2004;22(23-24):2966-73.
2004: Patrick G Yeni; Scott M Hammer; Martin S Hirsch; Michael S Saag; Mauro Schechter; Charles C J Carpenter; Margaret A Fischl; José M Gatell; Brian G Gazzard; Donna M Jacobsen; David A Katzenstein; Julio S G Montaner; Douglas D Richman; Robert T Schooley; Melanie A Thompson; STEFANO VELLA; Paul A Volberding
Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association 2004;292(2):251-65.
2004: Esteban Martínez; Ana Milinkovic; Elisa De Lazzari; Giovanni Ravasi; José L Blanco; María Larrousse; Josep Mallolas; Felipe García; José M Miró; José M Gatell
Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adults.
Lancet 2004;364(9428):65-7.
2004: Pedro Cahn; José M Gatell; Kathleen Squires; Lisa D Percival; Peter J Piliero; Ian A Sanne; Sarah Shelton; Adriano Lazzarin; Linda Odeshoo; Thomas D Kelleher; Alexandra Thiry; Michael D Giordano; Stephen M Schnittman
Atazanavir--a once-daily HIV protease inhibitor that does not cause dyslipidemia in newly treated patients: results from two randomized clinical trials.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 2004;3(3):92-8.
2004: Felipe García; Montserrat Plana; Mireia Arnedo; Mercè Brunet; Pedro Castro; Cristina Gil; Elena Vidal; Olga Millán; Anna López; Jaume Martorell; Emilio Fumero; José M Miró; José Alcamí; Tomás Pumarola; Teresa Gallart; José M Gatell
Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection: a randomized pilot study.
Journal of acquired immune deficiency syndromes (1999) 2004;36(3):823-30.
2004: Montserrat Plana; Felipe Garcia; Annette Oxenius; Gabriel M Ortiz; Anna Lopez; Anna Cruceta; Gabriel Mestre; Emilio Fumero; Catherine Fagard; Maria Antonia Sambeat; Ferran Segura; José M Miró; Mireia Arnedo; Lucia Lopalcos; Tomás Pumarola; Bernard Hirschel; Rodney E Phillips; Douglas F Nixon; Teresa Gallart; José M Gatell
Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3.
Journal of acquired immune deficiency syndromes (1999) 2004;36(3):791-9.
2004: Felipe García; Elisa De Lazzari; Montserrat Plana; Pedro Castro; Gabriel Mestre; Meritxell Nomdedeu; Emilio Fumero; Esteban Martínez; Josep Mallolas; José L Blanco; José M Miró; Tomás Pumarola; Teresa Gallart; José M Gatell
Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count.
Journal of acquired immune deficiency syndromes (1999) 2004;36(2):702-13.
2004: Jordi Blanch; Araceli Rousaud; Esteban Martinez; Elisa De Lazzari; Ana Milinkovic; Josep-Maria Peri; José L Blanco; Jesús Jaen; Victor Navarro; Guillem Massana; José M Gatell
Factors associated with severe impact of lipodystrophy on the quality of life of patients infected with HIV-1.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(10):1464-70.
2004: Alfonso Casado; Xavier Badia; Ezequiel Consiglio; Elena Ferrer; Alicia González; Enric Pedrol; José M Gatell; C Azuaje; Josep M Llibre; Miquel Aranda; Pilar Barrufet; Javier Martínez-Lacasa; Daniel Podzamczer
Health-related quality of life in HIV-infected naive patients treated with nelfinavir or nevirapine associated with ZDV/3TC (the COMBINE-QoL substudy).
HIV clinical trials 2004;5(3):132-9.
2004: Natividad Benito; Asunción Moreno; Xavier Filella; José M Miró; Julià González; Tomás Pumarola; María Eugenia Valls; Montserrat Luna; Felipe García; Ana Rañó; Antoni Torres; José M Gatell
Inflammatory responses in blood samples of human immunodeficiency virus-infected patients with pulmonary infections.
Clinical and diagnostic laboratory immunology 2004;11(3):608-14.
2004: Montserrat Plana; Elena Ferrer; Catalina Martínez; Daniel Podzamczer; Felipe García; María J Maleno; Juan J Barceló; Ana García; Maria J Barberá; Montserrat Lacarcel; José M Miró; Teresa Gallart; José M Gatell
Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.
Antiviral therapy 2004;9(2):197-204.
2004: Federico Pulido; José R Arribas; José M Miró; María A Costa; Juan González; Rafael Rubio; Jose Peña; Miguel Torralba; Montserrat Lonca; Alicia Lorenzo; Concepción Cepeda; Juan J Vázquez; José M Gatell
Clinical, virologic, and immunologic response to efavirenz-or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study).
Journal of acquired immune deficiency syndromes (1999) 2004;35(4):343-50.
2004: Esteban Martínez; Pere Domingo; María J Galindo; Ana Milinkovic; Juan A Arroyo; Francisco Baldovi; María Larrousse; Agathe León; Elisa De Lazzari; José M Gatell
Risk of metabolic abnormalities in patients infected with HIV receiving antiretroviral therapy that contains lopinavir-ritonavir.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(7):1017-23.
2004: Emilio Fumero; Felipe García; José M Gatell
Immunosuppressive drugs as an adjuvant to HIV treatment.
The Journal of antimicrobial chemotherapy 2004;53(3):415-7.
2004: Sònia López; Oscar Miró; Esteban Martínez; Enric Pedrol; Benjamín Rodríguez-Santiago; Ana Milinkovic; Anna Soler; Miguel A García-Viejo; Virginia Nunes; Jordi Casademont; José M Gatell; Francesc Cardellach
Mitochondrial effects of antiretroviral therapies in asymptomatic patients.
Antiviral therapy 2004;9(1):47-55.
2004: Ulrich A Walker; Jochen Bäuerle; Montserrat Laguno; Javier Murillas; Stefan Mauss; Guenther Schmutz; Bernhard Setzer; Rosa Miquel; José M Gatell; Josep Mallolas
Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine.
Hepatology (Baltimore, Md.) 2004;39(2):311-7.
2003: Pilar Navarrete; Vanesa Morente; Felipe García; Llucia Alós; Mireia Arnedo; Montserrat Plana; Cristina Gil; Miguel Caballero; José M Miró; Esteban Martínez; Emilio Fumero; Pedro Castro; José L Blanco; Josep Mallolas; Jordi Blanch; Anna Cruceta; Gabriel Mestre; Tomás Pumarola; Teresa Gallart; José M Gatell
Predictors of tonsillar tissue HIV-1 viral burden at baseline and after 1 year of antiretroviral therapy.
Antiviral therapy 2003;8(6):635-7.
2003: Oscar Miró; Sònia López; Esteban Martínez; Benjamín Rodríguez-Santiago; José L Blanco; Ana Milinkovic; Jose M Miró; Virginia Nunes; Jordi Casademont; José M Gatell; Francesc Cardellach
Short communication: reversible mitochondrial respiratory chain impairment during symptomatic hyperlactatemia associated with antiretroviral therapy.
AIDS research and human retroviruses 2003;19(11):1027-32.
2003: Esteban Martínez; Pere Domingo; Esteban Ribera; Ana Milinkovic; Juan A Arroyo; Ignacio Conget; José B Pérez-Cuevas; Roser Casamitjana; Elisa De Lazzari; Luis Bianchi; Enric Montserrat; Merce Roca; Rosa Burgos; Juan A Arnaiz; José M Gatell
Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitors.
Antiviral therapy 2003;8(5):403-10.
2003: L Martí; A Moreno; Xavier Filella; José Luis Marín; Manel Almela; Natividad Benito; Miquel Sánchez; José M Gatell
[Cytokines value as a sepsis and mortality predictor in elderly patients with fever].
Medicina clínica 2003;121(10):361-6.
2003: Esteban Martínez; Juan A Arnaiz; Daniel Podzamczer; David Dalmau; Esteban Ribera; Pere Domingo; Hernando Knobel; Melcior Riera; Enric Pedrol; Lluís Force; Josep M Llibre; Ferran Segura; Cristóbal Richart; Cristina Cortés; Manuel Javaloyas; Miquel Aranda; Anna Cruceta; Elisa De Lazzari; José M Gatell
Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection.
The New England journal of medicine 2003;349(11):1036-46.
2003: Oscar Miró; Sònia López; Enric Pedrol; Benjamín Rodríguez-Santiago; Esteban Martínez; Anna Soler; Ana Milinkovic; Jordi Casademont; Virginia Nunes; José M Gatell; Francesc Cardellach
Mitochondrial DNA depletion and respiratory chain enzyme deficiencies are present in peripheral blood mononuclear cells of HIV-infected patients with HAART-related lipodystrophy.
Antiviral therapy 2003;8(4):333-8.
2003: Catherine Fagard; Annette Oxenius; Huldrych Günthard; Felipe Garcia; Michelle Le Braz; Gabriel Mestre; Manuel Battegay; Hansjakob Furrer; Pietro Vernazza; Enos Bernasconi; Amalio Telenti; Rainer Weber; Dominique Leduc; Sabine Yerly; David Price; Sara J Dawson; Thomas Klimkait; Thomas V Perneger; Angela McLean; Bonaventura Clotet; José M Gatell; Luc Perrin; Montserrat Plana; Rodney Phillips; Bernard Hirschel
A prospective trial of structured treatment interruptions in human immunodeficiency virus infection.
Archives of internal medicine 2003;163(10):1220-6.
2003: Remko van Leeuwen; Christine Katlama; Robert L Murphy; Kathleen E Squires; José M Gatell; Andrzej Horban; Bonaventura Clotet; Shlomo Staszewski; Arne van Eeden; Nathan Clumeck; Mauro Moroni; Andrew T Pavia; Reinhold E Schmidt; Juan Gonzalez-Lahoz; Julio Montaner; Francisco Antunes; Roy M Gulick; Dénes Bánhegyi; Marc van der Valk; Peter Reiss; Liesbeth van Weert; Frank van Leth; Victoria A Johnson; Jean-Pierre Sommadossi; Joep M A Lange
A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.
AIDS (London, England) 2003;17(7):987-99.
2003: Juan A Arnaiz; Josep Mallolas; Daniel Podzamczer; Jan Gerstoft; Jens D Lundgren; Pedro Cahn; Gerd Fätkenheuer; Antonella d'Arminio Monforte; Arnaldo Casiró; Peter Reiss; David Burger; Michael Stek; José M Gatell
Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load.
AIDS (London, England) 2003;17(6):831-40.
2003: Elena Ferrer; Daniel Podzamczer; Mireia Arnedo; Emilio Fumero; Paula McKenna; Alex Rinehart; José L Pérez; María J Barberá; Tomás Pumarola; José M Gatell; Francesc Gudiol
Genotype and phenotype at baseline and at failure in human immunodeficiency virus-infected antiretroviral-naive patients in a randomized trial comparing zidovudine and lamivudine plus nelfinavir or nevirapine.
The Journal of infectious diseases 2003;187(4):687-90.
2003: Juan P Horcajada; Tomás Pumarola; José Antonio Martínez; G Tapias; Jose-Maria Bayas; M de la Prada; F García; Carles Codina; José M Gatell; M Teresa Jiménez de Anta
A nosocomial outbreak of influenza during a period without influenza epidemic activity.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2003;21(2):303-7.
2003: Felipe García; Montserrat Plana; Mireia Arnedo; Gabriel M Ortiz; José M Miró; Lucia Lopalco; Franco Lori; Tomás Pumarola; Teresa Gallart; José M Gatell
A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions: a randomized study.
AIDS (London, England) 2003;17(1):43-51.
2003: J E Losa; Jose M Miro; Ana del Rio; A Moreno-Camacho; F Garcia; Xavier Claramonte; F Marco; C A Mestres; Manel Azqueta; José M Gatell
Infective endocarditis not related to intravenous drug abuse in HIV-1-infected patients: report of eight cases and review of the literature.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2003;9(1):45-54.
2002: Carme Vidal; Mireia Arnedo; Felipe Garcia; Gabriel Mestre; Montserrat Plana; Anna Cruceta; Alicia Capon; Teresa Gallart; José M Miro; Tomás Pumarola; José M Gatell
Genotypic and phenotypic resistance patterns in early-stage HIV-1-infected patients failing initial therapy with stavudine, didanosine and nevirapine.
Antiviral therapy 2002;7(4):283-7.
2002: Jordi Blanch; Araceli Rousaud; Esteban Martínez; Elisa De Lazzari; Josep-Maria Peri; Ana Milinkovic; Jose-Bernardo Perez-Cuevas; José L Blanco; José M Gatell
Impact of lipodystrophy on the quality of life of HIV-1-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2002;31(4):404-7.
2002: Carles Codina; Mireia Martínez; Montserrat Tuset; Elena del Cacho; María Teresa Martín; José M Miró; Josep Mallolas; Elisa De Lazzari; Felipe García; Esteban Martínez; José M Gatell; Josep Ribas
[Comparison of three methods to calculate adherence in patients receiving antiretroviral treatment].
Enfermedades infecciosas y microbiología clínica 2002;20(10):484-90.
2002: Timothy W Schacker; Phuong L Nguyen; Esteban Martinez; Cavan Reilly; José M Gatell; Andrzej Horban; Elzbieta Bakowska; Baiba Berzins; Remko van Leeuwen; Steven Wolinsky; Ashley T Haase; Robert L Murphy
Persistent abnormalities in lymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy.
The Journal of infectious diseases 2002;186(8):1092-7.
2002: Alex Soriano; Catalina Martínez; Felipe García; Montserrat Plana; Eduard Palou; Marylène Lejeune; Juan I Aróstegui; Elisa De Lazzari; Carmen Rodriguez; Alicia Barrasa; José I Lorenzo; José Alcamí; Jorge del Romero; José M Miró; José M Gatell; Teresa Gallart
Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3'A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression.
The Journal of infectious diseases 2002;186(7):922-31.
2002: Felipe García; Montserrat Plana; Gabriel Mestre; Mireia Arnedo; Cristina Gil; José M Miró; Anna Cruceta; Tomás Pumarola; Teresa Gallart; José M Gatell
Immunological and virological factors at baseline may predict response to structured therapy interruption in early stage chronic HIV-1 infection.
AIDS (London, England) 2002;16(13):1761-5.
2002: Felipe Garcia; Montserrat Plana; Gabriel Mestre; Anna Cruceta; Esteban Martinez; José M Miró; Josep Mallolas; Montserrat Tuset; Tomas Pumorola; Teresa Gallart; José M Gatell
Metabolic and immunological effects of antiretroviral agents in healthy individuals receiving post-exposure prophylaxis.
Antiviral therapy 2002;7(3):195-7.
2002: José R Arribas; Federico Pulido; José M Miró; María A Costa; Juan González; Rafael Rubio; Jose Peña; Miguel Torralba; Montserrat Lonca; Alicia Lorenzo; Amalia del Palacio; Juan J Vázquez; José M Gatell
High effectiveness of efavirenz-based highly active antiretroviral therapy in HIV-1-infected patients with fewer than 100 CD4 cells/microl and opportunistic diseases: the EfaVIP Study (Efavirenz in Very Immunosuppressed Patients).
AIDS (London, England) 2002;16(11):1554-6.
2002: Esteban Martínez; José M Miró; Benito Almirante; Jose M Aguado; Pedro Fernandez-Viladrich; Manuel L Fernandez-Guerrero; Jose L Villanueva; Fernando Dronda; Alfonso Moreno-Torrico; Miguel Montejo; Pedro Llinares; José M Gatell
Effect of penicillin resistance of Streptococcus pneumoniae on the presentation, prognosis, and treatment of pneumococcal endocarditis in adults.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(2):130-9.
2002: Patrick G Yeni; Scott M Hammer; Charles C J Carpenter; David A Cooper; Margaret A Fischl; José M Gatell; Brian G Gazzard; Martin S Hirsch; Donna M Jacobsen; David A Katzenstein; Julio S G Montaner; Douglas D Richman; Michael S Saag; Mauro Schechter; Robert T Schooley; Melanie A Thompson; STEFANO VELLA; Paul A Volberding
Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association 2002;288(2):222-35.
2002: Felipe García; Bonaventura Clotet; Santiago Moreno; Juan Carlos López Bernaldo De Quirós; José M Gatell
[Treatment interruptions in clinical practice].
Enfermedades infecciosas y microbiología clínica 2002;20 Suppl 2():68-73.
2002: Cecilia Tortajada; Bernardo Pérez-Cuevas; Asuncion Moreno; Esteban Martínez; Josep Mallolas; Felipe García; Eugenia Valls; José M Miró; Esther De Lazzari; José M Gatell
Highly active antiretroviral therapy (HAART) modifies the incidence and outcome of visceral leishmaniasis in HIV-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2002;30(3):364-6.
2002: Antonia Sambola; Jose M Miro; MP Tornos; Benito Almirante; A Moreno-Torrico; M Gurgui; E Martinez; Ana del Rio; Manel Azqueta; F Marco; José M Gatell
Streptococcus agalactiae infective endocarditis: analysis of 30 cases and review of the literature, 1962-1998.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(12):1576-84.
2002: Daniel Podzamczer; Elena Ferrer; Ezequiel Consiglio; José M Gatell; Pepa Perez; José Luis Perez; Elena Luna; Alicia González; Enric Pedrol; Luisa Lozano; Imma Ocaña; Josep M Llibre; Arnaldo Casiró; Miquel Aranda; Pilar Barrufet; Javier Martínez-Lacasa; José M Miró; Xavier Badía; Alfonso Casado; Sergio Lupo; Pedro Cahn; Manel Maños; Jordi Estela
A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study).
Antiviral therapy 2002;7(2):81-90.
2002: Rafael Rubio; Juan Berenguer; José M Miró; Antonio Antela; José A Iribarren; Juan González; Luis Guerra; Santiago Moreno; Julio Arrizabalaga; Buenaventura Clotet; José M Gatell; Fernando Laguna; Esteban Martínez; Francisco Parras; Juan Miguel Santamaría; Montserrat Tuset; Pompeyo E. Viciana
[Recommendations of the Spanish AIDS Study Group (GESIDA) and the National Aids Plan (PNS) for antiretroviral treatment in adult patients with human immunodeficiency virus infection in 2002].
Enfermedades infecciosas y microbiología clínica 2002;20(6):244-303.
2002: Montserrat Plana; Catalina Martínez; Felipe García; María J Maleno; Juan J Barceló; Ana García; Marylène Lejeune; Carmen Vidal; Anna Cruceta; José M Miró; Tomás Pumarola; Teresa Gallart; José M Gatell
Immunologic reconstitution after 1 year of highly active antiretroviral therapy, with or without protease inhibitors.
Journal of acquired immune deficiency syndromes (1999) 2002;29(5):429-34.
2002: Jordi Blanch; Araceli Rousaud; Martin Hautzinger; Esteban Martínez; Josep-Maria Peri; Susana Andrés; Esteve Cirera; José M Gatell; Cristóbal Gastó
Assessment of the efficacy of a cognitive-behavioural group psychotherapy programme for HIV-infected patients referred to a consultation-liaison psychiatry department.
Psychotherapy and psychosomatics 2002;71(2):77-84.
2002: Jens D Lundgren; Amanda Mocroft; José M Gatell; bruno ledergerber; Antonella d'Arminio Monforte; Philippe Hermans; Frank-Detlef Goebel; Anders Blaxhult; Ole Kirk; Andrew N Phillips
A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA study.
The Journal of infectious diseases 2002;185(2):178-87.
2001: M Saras-Nacenta; Y López-Púa; L F Lípez-Cortés; Josep Mallolas; José M Gatell; Xavier Carné
Determination of efavirenz in human plasma by high-performance liquid chromatography with ultraviolet detection.
Journal of chromatography. B, Biomedical sciences and applications 2001;763(1-2):53-9.
2001: José M Gatell
From amprenavir to GW433908.
Journal of HIV therapy 2001;6(4):95-9.
2001: Esteban Martínez; Mireia Arnedo; Vicente Giner; Cristina Gil; Miguel Caballero; Llucia Alós; Felipe García; C Holtzer; Josep Mallolas; José M Miró; Tomás Pumarola; José M Gatell
Lymphoid tissue viral burden and duration of viral suppression in plasma.
AIDS (London, England) 2001;15(12):1477-82.
2001: Jordi Blanch; Esteban Martínez; Araceli Rousaud; José L Blanco; Miguel A García-Viejo; Josep-Maria Peri; Josep Mallolas; Elisa De Lazzari; Joan de Pablo; José M Gatell
Preliminary data of a prospective study on neuropsychiatric side effects after initiation of efavirenz.
Journal of acquired immune deficiency syndromes (1999) 2001;27(4):336-43.
2001: Esteban Martínez; José L Blanco; Juan A Arnaiz; José B Pérez-Cuevas; A Mocroft; Anna Cruceta; María Angeles Marcos; Ana Milinkovic; Miguel A García-Viejo; Josep Mallolas; Xavier Carné; A Phillips; José M Gatell
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy.
AIDS (London, England) 2001;15(10):1261-8.
2001: M Sarasa-Nacenta; Y López-Púa; Josep Mallolas; José L Blanco; José M Gatell; Xavier Carné
Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatography.
Journal of chromatography. B, Biomedical sciences and applications 2001;757(2):325-32.
2001: Felipe García; Montserrat Plana; Gabriel M Ortiz; Sebastian Bonhoeffer; A Soriano; Carme Vidal; Anna Cruceta; Mireia Arnedo; Cristina Gil; G Pantaleo; Tomás Pumarola; Teresa Gallart; D F Nixon; José M Miró; José M Gatell
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection.
AIDS (London, England) 2001;15(9):F29-40.
2001: Natividad Benito; Ana Rañó; A Moreno; Julià González; M Luna; C Agustí; Cristina Danés; Tomás Pumarola; José M Miró; Antoni Torres; José M Gatell
Pulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy era in Spain.
Journal of acquired immune deficiency syndromes (1999) 2001;27(1):35-43.
2001: Esteban Martinez; A Mocroft; Miguel A García-Viejo; José B Pérez-Cuevas; José L Blanco; Josep Mallolas; Luis Bianchi; Ignacio Conget; Jordi Blanch; A Phillips; José M Gatell
Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study.
Lancet 2001;357(9256):592-8.
2001: José M Gatell; José L Blanco; José Alcamí; Antonio Antela; Julio Arrizabalaga; J L Casado; Bonaventura Clotet; R Delgado; Alejo Erice; Luis Guerra; A Guerrero; José A Iribarren; M Leal; J C López; Luis Menéndez-Arias; José M Miró; Santiago Moreno; JL Pérez; Tomás Pumarola; Rafael Rubio; L Ruiz; Juan Miguel Santamaría; V Soriano; A Telenti; Pompeyo E. Viciana
[GESIDA Consensus document on the use of resistance studies in clinical practice].
Enfermedades infecciosas y microbiología clínica 2001;19(Monografico):53-60.
2001: Amanda Mocroft; Andrew N Phillips; Veronica Miller; José M Gatell; Jan van Lunzen; J M Parkin; R Weber; B Roge; Adriano Lazzarin; Jens D Lundgren
The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study.
AIDS (London, England) 2001;15(2):201-9.
2001: Felipe Garcia; Montserrat Plana; A Soriano; Carme Vidal; Mireia Arnedo; Cristina Gil; Anna Cruceta; Tomás Pumarola; Teresa Gallart; José M Miro; José M Gatell
Predictors of progression in chronically infected naive patients with plasma viraemia below 5000 copies/ml and CD4 T lymphocytes greater than 500 x 10(6)/I.
AIDS (London, England) 2001;15(1):131-3.
2001: Esteban Martínez; M A Garcia-Viejo; L Blanch; José M Gatell
Lipodystrophy syndrome in patients with HIV infection: quality of life issues.
Drug safety : an international journal of medical toxicology and drug experience 2001;24(3):157-66.
2001: C Alves; J M Nicolás; José M Miró; Antoni Torres; C Agustì; J Gonzalez; A Raño; N Benito; A Moreno; F Garcìa; J Millá; José M Gatell
Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2001;17(1):87-93.
2000: Cecilia Tortajada; Felipe Garcia; Montserrat Plana; Teresa Gallart; María J Maleno; José M Miró; José M Gatell
Comparison of T-cell subsets' reconstitution after 12 months of highly active antiretroviral therapy initiated during early versus advanced states of HIV disease.
Journal of acquired immune deficiency syndromes (1999) 2000;25(4):296-305.
2000: Esteban Martínez; Miguel A García-Viejo; María Angeles Marcos; José B Pérez-Cuevas; José L Blanco; Josep Mallolas; José M Miró; José M Gatell
Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy.
AIDS (London, England) 2000;14(16):2615-7.
2000: Felipe García; Hernando Knobel; Maria Antonia Sambeat; Julio Arrizabalaga; Miquel Aranda; Joan Romeu; David Dalmau; Ferran Segura; JL Gomez-Sirvent; Elena Ferrer; Anna Cruceta; Teresa Gallart; Tomás Pumarola; José M Miró; José M Gatell
Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the scan study.
AIDS (London, England) 2000;14(16):2485-94.
2000: Josep Mallolas; José L Blanco; María Sarasa; Vicente Giner; Esteban Martínez; Miguel A García-Viejo; Juan A Arnaiz; Anna Cruceta; Dolors Soy; Montserrat Tuset; Alex Soriano; Carles Codina; Tomás Pumarola; Xavier Carné; José M Gatell
Dose-finding study of once-daily indinavir/ritonavir plus zidovudine and lamivudine in HIV-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2000;25(3):229-35.
2000: Esteban Martínez; Miguel A García-Viejo; José L Blanco; Luis Bianchi; E Buira; Ignacio Conget; Roser Casamitjana; Josep Mallolas; José M Gatell
Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;31(5):1266-73.
2000: José M Miró; Antonio Antela; Julio Arrizabalaga; Bonaventura Clotet; José M Gatell; Luis Guerra; J Antonio Iribarren; Fernando Laguna; Santiago Moreno; Francisco Parras; Rafael Rubio; Juan Miguel Santamaría; Pompeyo E. Viciana
[Recommendations of GESIDA (Grupo de Estudio de SIDA)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (II)].
Enfermedades infecciosas y microbiología clínica 2000;18(8):396-412.
2000: Montserrat Plana; Felipe García; Teresa Gallart; Cecilia Tortajada; Alex Soriano; Eduard Palou; María J Maleno; Juan J Barceló; C Vidal; Anna Cruceta; José M Miró; José M Gatell
Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
AIDS (London, England) 2000;14(13):1921-33.
2000: Felipe García; M M Alonso; Joan Romeu; Hernando Knobel; Julio Arrizabalaga; Elena Ferrer; David Dalmau; I Ruiz; Francesc Vidal; A Frances; Ferran Segura; JL Gomez-Sirvent; Anna Cruceta; Bonaventura Clotet; Tomás Pumarola; Teresa Gallart; WA O'Brien; José M Miró; José M Gatell
Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish EARTH-2 Study. Early Anti-Retroviral Therapy Study.
Journal of acquired immune deficiency syndromes (1999) 2000;25(1):26-35.
2000: José M Miró; Antonio Antela; Julio Arrizabalaga; Bonaventura Clotet; José M Gatell; Luis Guerra; José A Iribarren; Fernando Laguna; Santiago Moreno; Francisco Parras; Rafael Rubio; Juan Miguel Santamaría; Pompeyo E. Viciana
[Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)].
Enfermedades infecciosas y microbiología clínica 2000;18(7):329-51.
2000: Anders Blaxhult; Ole Kirk; C Pedersen; M Dietrich; S E Barton; José M Gatell; F Mulcahy; Bernard Hirschel; Amanda Mocroft; Jens D Lundgren
Regional differences in presentation of AIDS in Europe.
Epidemiology and infection 2000;125(1):143-51.
2000: Daniel Podzamczer; José M Miró; Elena Ferrer; José M Gatell; José-María Ramón; Esteban Ribera; Guillem Sirera; Anna Cruceta; Hernando Knobel; Pere Domingo; Rosa Polo; María Leyes; Jaime Cosin; M Carmen Fariñas; Julio Arrizabalaga; Javier Martínez-Lacasa; Francesc Gudiol
Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(2):89-95.
2000: F García; C Vidal; Montserrat Plana; Anna Cruceta; Teresa Gallart; Tomás Pumarola; José M Miro; José M Gatell
Residual low-level viral replication could explain discrepancies between viral load and CD4+ cell response in human immunodeficiency virus-infected patients receiving antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(2):392-4.
2000: Charles C J Carpenter; D A Cooper; Margaret A Fischl; José M Gatell; Brian G Gazzard; Scott M Hammer; Martin S Hirsch; Donna M Jacobsen; David A Katzenstein; Julio S G Montaner; Douglas D Richman; Michael S Saag; Mauro Schechter; Robert T Schooley; Melanie A Thompson; STEFANO VELLA; Patrick G Yeni; Paul A Volberding
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association 2000;283(3):381-90.
2000: Carles Codina; José M Miró; Montserrat Tuset; J Claramonte; Carmen Gomar; R Gotsens; B Gómez; S Suárez; Rosa Abellana; Carlos Ascaso; Ramon Cartaña; E Rodríguez; Miguel A Asenjo; Xavier Carné; Antoni Trilla; Francesc Marco; J Gómez; M Brunet; José L Pomar; José M Gatell; Josep Ribas
[Vancomycin and teicoplanin use as antibiotic prophylaxis in cardiac surgery: pharmacoeconomic study].
Medicina clínica 2000;114 Suppl 3():54-61.
1999: Felipe García; Joan Romeu; Imma Grau; Maria Antonia Sambeat; David Dalmau; Hernando Knobel; JL Gomez-Sirvent; Julio Arrizabalaga; Anna Cruceta; Bonaventura Clotet; Daniel Podzamczer; Tomás Pumarola; Teresa Gallart; WA O'Brien; José M Miró; José M Gatell
A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
AIDS (London, England) 1999;13(17):2377-88.
1999: Amanda Mocroft; Sara Madge; Anne M Johnson; Adriano Lazzarin; Nathan Clumeck; Frank-Detlef Goebel; Jean-Paul Viard; José M Gatell; Anders Blaxhult; Jens D Lundgren
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival.
Journal of acquired immune deficiency syndromes (1999) 1999;22(4):369-78.
1999: Felipe García; G Niebla; Joan Romeu; Carme Vidal; Montserrat Plana; M Ortega; L Ruiz; Teresa Gallart; B Clotet; José M Miró; Tomás Pumarola; José M Gatell
Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication.
AIDS (London, England) 1999;13(12):1491-6.
1999: Esteban Martínez; M Leguizamón; Josep Mallolas; José M Miró; José M Gatell
Influence of environmental temperature on incidence of indinavir-related nephrolithiasis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(2):422-5.
1999: Felipe García; Montserrat Plana; Carme Vidal; Anna Cruceta; WA O'Brien; G Pantaleo; Tomás Pumarola; Teresa Gallart; José M Miró; José M Gatell
Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy.
AIDS (London, England) 1999;13(11):F79-86.
1999: F Vidal; J Mensa; J A Martínez; Manel Almela; F Marco; José M Gatell; C Richart; E Soriano; M Teresa Jiménez de Anta
Pseudomonas aeruginosa bacteremia in patients infected with human immunodeficiency virus type 1.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(7):473-7.
1999: José M Gatell
Coming therapies: amprenavir.
International journal of clinical practice. Supplement 1999;103():42-4.
1999: Esteban Martínez; I Conget; L Lozano; R Casamitjana; José M Gatell
Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine.
AIDS (London, England) 1999;13(7):805-10.
1998: Esteban Martínez; José M Gatell; Y Morán; E Aznar; E Buira; Ana Guelar; Josep Mallolas; Eladio Soriano
High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(6):1510-3.
1998: Esteban Ribera; José M Miró; E Cortés; Anna Cruceta; J Merce; F Marco; Ana M Planes; J C Paré; A Moreno; Imma Ocaña; José M Gatell; Albert Pahissa
Influence of human immunodeficiency virus 1 infection and degree of immunosuppression in the clinical characteristics and outcome of infective endocarditis in intravenous drug users.
Archives of internal medicine 1998;158(18):2043-50.
1998: Santiago Moreno; Julio Arrizabalaga; José M Gatell; Bonaventura Clotet; Koldo Aguirrebengoa; Antonio Antela; José A Iribarren; Fernando Laguna; José M Miró; Imma Ocaña; R Rubio; Pompeyo E. Viciana; Daniel Podzamczer
[Recommendations for antiretroviral treatment in 1998. AIDS Working Group of the Spanish Society for Infectious Diseases and Clinical Microbiology (SEIMC)].
Enfermedades infecciosas y microbiología clínica 1998;16(8):374-6.
1998: C Vidal; Felipe García; José M Gatell; M Leal; B Clotet; Tomás Pumarola; José M Miró; Josep Mallolas; L Ruiz; Anna Cruceta; Cecilia Tortajada
Predictive factors influencing peak viral load drop in response to nucleoside reverse transcriptase inhibitors in antiretroviral-naive HIV-1-infected patients.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;19(1):55-60.
1998: C Vidal; Felipe García; Joan Romeu; L Ruiz; José M Miró; Anna Cruceta; A Soriano; Tomás Pumarola; Bonaventura Clotet; José M Gatell
Lack of evidence of a stable viral load set-point in early stage asymptomatic patients with chronic HIV-1 infection.
AIDS (London, England) 1998;12(11):1285-9.
1998: S Moreno; Julio Arrizabalaga; José M Gatell; Bonaventura Clotet; Koldo Aguirrebengoa; A Antela; José A Iribarren; Fernando Laguna; José M Miró; Imma Ocaña; R Rubio; Pompeyo E. Viciana; Daniel Podzamczer
[Recommendations on antiretroviral treatment. The AIDS Study Group of the Spanish Society of Infectious Diseases and Clinical Microbiology].
Medicina clínica 1998;110(3):109-16.
1998: José M Miró; Julio Arrizabalaga; José M Gatell
[GESIDA survey on antiretroviral treatment in 1998. Working Group for the Study of AIDS (GESIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)].
Enfermedades infecciosas y microbiología clínica 1998;16 Suppl 1():69-70.
1997: Josep Mallolas; Julio Arrizabalaga; Montserrat Loncá; José M Gatell; A Adán; E Martínez-Chamorro; Cecilia Tortajada; Francisco Rodríguez Arrondo; A Blanco; Ana Guelar; E Soriano
Cytomegalovirus disease in HIV-1-infected patients treated with protease inhibitors.
AIDS (London, England) 1997;11(14):1785-7.
1997: FJ Muñoz-Rodríguez; S Padró; Pau Pastor; D Rosa-Re; María Eugenia Valls; José M Miró; José M Gatell
Pleural and peritoneal leishmaniasis in an AIDS patient.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1997;16(3):246-8.
1997: Josep Mallolas; José M Gatell; Juan Luis Gómez Sirvent; E Buira; L Zamora; J Alecrim-Andrade; A Adán; M Morales; José M Miró; M Lonća; Ana Guelar; Eladio Soriano
[Prophylaxis secondary to retinitis by CMV in patients with AIDS: the efficacy of an intermittent schedule of 3 days/week].
Enfermedades infecciosas y microbiología clínica 1997;15(2):61-4.
1997: Felipe García; Carme Vidal; José M Gatell; José M Miró; A Soriano; Tomás Pumarola
Viral load in asymptomatic patients with CD4+ lymphocyte counts above 500 x 10(6)/l.
AIDS (London, England) 1997;11(1):53-7.
1996: R Sala; José M Miró; E Feliu; J L Bianchi; José M Gatell; Joan Carles Reverter; Eladio Soriano; J García San Miguel
[In vitro effect of heroin on neutrophil polymorphonuclear leukocytes from peripheral blood].
Medicina clínica 1996;107(19):726-9.
1996: F Vidal; J Mensa; Manel Almela; J A Martínez; Francesc Marco; Cristina Casals; José M Gatell; Eladio Soriano; M Teresa Jimenez De Anta
Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes.
Archives of internal medicine 1996;156(18):2121-6.
1996: José M Gatell; Juan González-Lahoz; B Clotet; F Antunes; L Kasparova; A Gil-Aguado; P Saballs; J M Santamaria; Daniel Podzamczer; J M Miro; A Jou; J Verdejo; Manuela Doroana; J Thomis
Switching from zidovudine to didanosine in patients with symptomatic HIV infection and disease progression. ddI Iberian Study Group.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;12(3):249-58.
1996: L Zamora; Josep Mallolas; José M Gatell
Prophylaxis of pneumocystis pneumonia and toxoplasmosis.
Annals of internal medicine 1996;124(12):1096.
1996: E Buira; José M Gatell; L Zamora; Josep Mallolas; José M Miró; Eladio Soriano
[Analysis of 1,187 consecutive cases of AIDS: variations and trends in time].
Enfermedades infecciosas y microbiología clínica 1996;14(5):290-5.
1996: José M Gatell; M Leal; J Mallolas; Carme Vidal; Tomás Pumarola; R Parra; S Padró; Antonio Caruz; T Falgueras; C Rey; Armando Sánchez-Quijano; Y Torres; Eduardo Lissen; M T Jiménez de Anta; E Soriano
A pilot case-control study of zidovudine compared with zidovudine plus didanosine in patients with advanced HIV-1 disease and no previous experience with antiretrovirals.
Antiviral therapy 1996;1(2):105-12.
1995: Daniel Podzamczer; José M Miró; F Bolao; José M Gatell; J Cosín; G Sirera; P Domingo; F Laguna; J Santamaría; J Verdejo
Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group.
Annals of internal medicine 1995;123(3):175-80.
1995: Antoni Trilla; Carles Codina; M Salles; José M Gatell; M Zaragoza; Francesc Marco; M Navasa; J Mulet; J Ribas; M Teresa Jimenez De Anta
A cluster of fever and hypotension on a surgical intensive care unit related to the contamination of plasma expanders by cell wall products of Bacillus stearothermophilus.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1995;16(6):335-9.
1995: P Fernandez; Antoni Torres; J M Miro; C Vieigas; Josep Mallolas; L Zamora; José M Gatell; María Eugenia Valls; R Riquelme; R Rodríguez-Roisin
Prognostic factors influencing the outcome in pneumocystis carinii pneumonia in patients with AIDS.
Thorax 1995;50(6):668-71.
1995: O Miró; A Moreno; María Eugenia Valls; José M Miró; J M Piqué; Josep Bordas; Antonio Moreno-Martínez; J A Bombí; José M Gatell
[Intestinal microsporidiosis in patients with AIDS: study of 3 cases].
Medicina clínica 1995;104(3):96-9.
1994: J Galofré; A Moreno; Josep Mensa; José M Miró; José M Gatell; Manel Almela; X Claramonte; L Lozano; Antoni Trilla; Josep Mallolas
Analysis of factors influencing the outcome and development of septic metastasis or relapse in Salmonella bacteremia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;18(6):873-8.
1994: José M Miró; E Buira; Josep Mallolas; Teresa Gallart; A Moreno; L Zamora; R Vilella; José M Gatell; Eladio Soriano
[CD4+ lymphocytes and opportunistic infections and neoplasms in patients with human immunodeficiency virus infection].
Medicina clínica 1994;102(15):566-70.
1994: Ana Guelar; José M Miró; Josep Mallolas; L Zamora; C Cardenal; José M Gatell; Eladio Soriano
[Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone].
Enfermedades infecciosas y microbiología clínica 1994;12(3):137-40.
1994: A Moreno; José M Gatell; Josep Mensa; María Eugenia Valls; Jordi Vila; X Claramonte; José M Miró; Josep Mallolas; L Zamora; L Lozano
[Incidence of enteropathogens in patients with human immunodeficiency virus infection].
Medicina clínica 1994;102(6):205-8.
1994: M Sans; José M Gatell; M Rafel; Josep Mallolas; Eladio Soriano
[Varicella pneumonia in adults infected by HIV-1. Presentation of 2 cases].
Enfermedades infecciosas y microbiología clínica 1994;12(1):26-30.
1993: Ana Guelar; José M Gatell; J Verdejo; Daniel Podzamczer; L Lozano; E Aznar; José M Miró; Josep Mallolas; L Zamora; J González
A prospective study of the risk of tuberculosis among HIV-infected patients.
AIDS (London, England) 1993;7(10):1345-9.
1993: José M Gatell
[HIV infection. When will the cure be found?].
Medicina clínica 1993;100 Suppl 1():35-6.
1993: C Montón; Josep Mallolas; José M Miró; M Alsina; José M Gatell; Eladio Soriano
[Epidemic Kaposi's sarcoma in women: presentation of 4 cases].
Medicina clínica 1993;100(5):179-80.
1993: Josep Mallolas; L Zamora; José M Gatell; José M Miró; E Vernet; María Eugenia Valls; Eladio Soriano; J G SanMiguel
Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
AIDS (London, England) 1993;7(1):59-64.
1992: J Bisbe; J M Miro; X Latorre; A Moreno; Josep Mallolas; José M Gatell; Jorge Puig de la Bellacasa; Eladio Soriano
Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;15(6):910-23.
1992: L Zamora; José M Gatell; J M Barrera; G Ercilla; C Gil; E Buira; J M Miro; Eladio Soriano
Influence on survival of p24 antigen levels in patients with AIDS or advanced AIDS related complex treated with zidovudine.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1992;11(12):1181-5.
1992: Enric Pedrol; Josep Mallolas; J M González-Clemente; José M Miró; A Azón; José M Gatell; A Moreno; Josep Mensa; E Soriano
[Cryptococcosis: presentation of 26 cases].
Medicina clínica 1992;98(10):361-5.
1992: E Buira; José M Gatell; José M Miró; J Batalla; L Zamora; Josep Mallolas; E Aznar; Eladio Soriano; J G San Miguel
Influence of treatment with zidovudine (ZDV) on the long-term survival of AIDS patients.
Journal of acquired immune deficiency syndromes 1992;5(7):737-42.
1991: M A Brancós; Pilar Peris; José M Miró; Ana Monegal; José M Gatell; Josep Mallolas; Josep Mensa; Sebastián García; José Muñoz-Gomez
Septic arthritis in heroin addicts.
Seminars in arthritis and rheumatism 1991;21(2):81-7.
1991: S Garcia; M L Lozano; José M Gatell; Eladio Soriano; R Ramon; J G Sanmiguel
Prophylaxis against infection. Single-dose cefonicid compared with multiple-dose cefamandole.
The Journal of bone and joint surgery. American volume 1991;73(7):1044-8.
1991: Josep Mallolas; L Zamora; José M Gatell; José M Miró; Eladio Soriano
Low-dose co-trimoxazole, aerosolised pentamidine, or dapsone plus pyrimethamine for prevention of Pneumocystis carinii pneumonia.
Lancet 1991;337(8750):1162-3.
1991: Antoni Trilla; José M Gatell; Josep Mensa; X Latorre; Manel Almela; E Soriano; M Teresa Jimenez De Anta; J Garcia San Miguel
Risk factors for nosocomial bacteremia in a large Spanish teaching hospital: a case-control study.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1991;12(3):150-6.
1991: Josep Mallolas; José M Gatell; José M Miró; F Marco; J Bisbe; M T Jiménez de Anta; Eladio Soriano
Analysis of prognostic factors in 274 consecutive episodes of Pseudomonas aeruginosa bacteremia.
Antibiotics and chemotherapy 1991;44():106-14.
1991: R Aznar; M Mateu; José M Miró; José M Gatell; Josep Maria Gimferrer; E Aznar; Josep Mallolas; Eladio Soriano; J Sanchez-Lloret
Antibiotic prophylaxis in non-cardiac thoracic surgery: cefazolin versus placebo.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 1991;5(10):515-8.
1990: J M González-Clemente; José M Miró; Enric Pedrol; R Alvarez; José M Gatell; Josep Mallolas; Francesc Graus; J M Mercader; Ana Guelar; M Teresa Jiménez de Anta
[Encephalic toxoplasmosis in patients with the acquired immunodeficiency syndrome. A clinico-radiological study and the therapeutic results in 78 cases].
Medicina clínica 1990;95(12):441-6.
1990: Josep Mallolas; María Eugenia Valls; José M Miró; José M Gatell; A Xaubet; C Picado; M T Jiménez de Anta; E Soriano
[Diagnosis of pneumonia caused by Pneumocystis carinii using induced sputum].
Enfermedades infecciosas y microbiología clínica 1990;8(8):511-3.
1990: M A Félez; José M Miró; Josep Mallolas; María Eugenia Valls; A Moreno; José M Gatell; Eladio Soriano
[Enteritis caused by Isospora belli in patients with the acquired immunodeficiency syndrome. Description of 9 cases].
Medicina clínica 1990;95(3):84-8.
1990: Enric Pedrol; J M González-Clemente; José M Gatell; Josep Mallolas; José M Miró; Francesc Graus; R Alvarez; J M Mercader; J Berenguer; M Teresa Jiménez de Anta
Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy.
AIDS (London, England) 1990;4(6):511-7.
1990: José M Gatell; José M Miró
[The acquired immunodeficiency syndrome after 10 years].
Medicina clínica 1990;94(11):420-2.
1990: Daniel Podzamczer; Francesc Gudiol; F Bolao; José M Gatell; B Clotet; José M Miró
[Treatment of the most common infections in patients with human immunodeficiency virus infection. Task-force on AIDS of the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica].
Enfermedades infecciosas y microbiología clínica 1990;8(3):161-75.
1989: Josep Mallolas; A Azón; José M Miró; Teresa Castel; José M Gatell
Epidemic Kaposi's sarcoma in Spanish AIDS patients.
AIDS (London, England) 1989;3(12):857.
1989: jordi rello; José M Gatell; Jaume Almirall; Josep M Campistol; J Gonzalez; J Puig de la Bellacasa
Evaluation of culture techniques for identification of catheter-related infection in hemodialysis patients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(7):620-2.
1989: José M Gatell; Daniel Podzamczer; B Clotet; C Estany; J M Miro
Natural history of HIV infection in European drug users.
AIDS (London, England) 1989;3(6):404.
1989: Jaume Almirall; J Gonzalez; jordi rello; Josep M Campistol; J Montoliu; J Puig de la Bellacasa; L Revert; José M Gatell
Infection of hemodialysis catheters: incidence and mechanisms.
American journal of nephrology 1989;9(6):454-9.
1988: Josep Mallolas; X Latorre; José M Gatell; José M Miró; A Francés; D Mariscal; Eladio Soriano
[Clinical analysis of the first consecutive 145 cases of acquired immunodeficiency syndrome].
Medicina clínica 1988;91(19):721-4.
1988: Eladio Soriano; Josep Mallolas; José M Gatell; X Latorre; José M Miró; M Pecchiar; J Mensa; Antoni Trilla; A Moreno
Characteristics of tuberculosis in HIV-infected patients: a case-control study.
AIDS (London, England) 1988;2(6):429-32.
1988: E Hernández; T Puyuelo; José M Gatell; J M Barrera; T Pumarola
[Occupational risk of infection by human immunodeficiency virus].
Medicina clínica 1988;90(19):767-8.
1988: J Bisbe; José M Gatell; J Puig; Josep Mallolas; J A Martinez; M Teresa Jimenez De Anta; Eladio Soriano
Pseudomonas aeruginosa bacteremia: univariate and multivariate analyses of factors influencing the prognosis in 133 episodes.
Reviews of infectious diseases 1988;10(3):629-35.
1988: Josep Mallolas; José M Gatell; M Rovira; J I Conget; Antoni Trilla; Eladio Soriano
Vertebral arch tuberculosis in two human immunodeficiency virus-seropositive heroin addicts.
Archives of internal medicine 1988;148(5):1125-7.
1988: Antoni Trilla; J A Martos; José M Gatell; X Latorre
[Meningoencephalitis and mononucleosis syndrome associated with acute infection by human immunodeficiency virus].
Medicina clínica 1988;90(1):42-3.
1988: José M Gatell; Antoni Trilla; X Latorre; Manel Almela; J Mensa; A Moreno; J M Miro; J A Martinez; M Teresa Jimenez De Anta; Eladio Soriano
Nosocomial bacteremia in a large Spanish teaching hospital: analysis of factors influencing prognosis.
Reviews of infectious diseases 1988;10(1):203-10.
1987: José M Miró; J Puig de la Bellacasa; F C Odds; B K Gill; J Bisbe; José M Gatell; J Gonzalez; X Latorre; M Teresa Jimenez De Anta; Eladio Soriano
Systemic candidiasis in Spanish heroin addicts: a possible source of infection.
The Journal of infectious diseases 1987;156(5):857-8.
1987: José M Gatell; S Garcia; L Lozano; Eladio Soriano; R Ramon; J G SanMiguel
Perioperative cefamandole prophylaxis against infections.
The Journal of bone and joint surgery. American volume 1987;69(8):1189-93.
1987: José M Gatell; F Ferran; V Araujo; M Bonet; Eladio Soriano; J Traserra; J G SanMiguel
Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides.
Antimicrobial agents and chemotherapy 1987;31(9):1383-7.
1987: jordi rello; José M Gatell; Manel Almela; M J Jiménez de Anta; J Andreu; Eladio Soriano; J García San Miguel
[Septicemia caused by Listeria monocytogenes in the adult].
Medicina clínica 1987;88(14):537-40.
1986: José M Gatell; jordi rello; J M Miro; J A Martinez; Eladio Soriano; J SanMiguel Garcia
Cloxacillin-induced neutropenia.
The Journal of infectious diseases 1986;154(2):372.
1986: M A Brancós; José M Gatell; Nuria Guañabens; José M Miró; M Romaní; R Ramón; J Rotés-Querol; J García San Miguel
[Prospective study of septic arthritis in a general hospital. Comparison of different risk groups and evaluation of a pre-established medico-surgical therapeutic protocol].
Medicina clínica 1986;87(2):45-8.
1986: X Latorre; José M Gatell; Tomás Pumarola; José M Miró; C Laborí; M Pifarré; J Vidal; M Teresa Jiménez de Anta; Eladio Soriano; A Pumarola
[Prevalence of antibodies against HTLV-III/LAV in subpopulations at risk of suffering the acquired immune deficiency syndrome].
Medicina clínica 1986;86(3):113-4.
1986: X Latorre; C Cuturi; J M Miro; I Anegon; José M Gatell; Teresa Gallart; M Bruguera; Tomás Pumarola; A Trilla; J Ginel
Lymphocyte subpopulations in Spanish parenteral drug addicts.
Scandinavian journal of infectious diseases 1986;18(1):71-8.
1985: José M Gatell; J G SanMiguel; L Zamora; V Araujo; C Castells; A Moreno; M T Jimenez de Anta; J L Marin; M Elena; A Ballesta
Tobramycin and amikacin nephrotoxicity. Value of serum creatinine versus urinary concentration of beta-2-microglobulin.
Nephron 1985;41(4):337-43.
1984: José M Miró; J Puig de la Bellacasa; José M Gatell; A Ginel; M Teresa Jiménez de Anta; A Pumarola; J García San Miguel
[Rate of mucosocutaneous carriers of staphylococci in heroin addicts of the Barcelona area and the microbiological characteristics of heroin and the material of injection].
Medicina clínica 1984;83(15):620-3.
1984: José M Gatell; J G SanMiguel; V Araujo; L Zamora; J Maña; M Ferrer; M Bonet; M Bohe; M T Jimenez de Anta
Prospective randomized double-blind comparison of nephrotoxicity and auditory toxicity of tobramycin and netilmicin.
Antimicrobial agents and chemotherapy 1984;26(5):766-9.
1984: José M Gatell; J Riba; M L Lozano; J Maña; R Ramon; J García SanMiguel
Prophylactic cefamandole in orthopaedic surgery.
The Journal of bone and joint surgery. American volume 1984;66(8):1219-22.
1983: José M Miró; M A Brancós; José M Gatell; J García San Miguel
[Additional data on septic osteoarthritis in drug addicts].
Medicina clínica 1983;81(16):738.
1983: José M Gatell; J G San Miguel; L Zamora; V Araujo; M Bonet; M Bohé; M T Jimenez de Anta; M Farré; M Elena; A Ballesta; J L Marin
Comparison of the nephrotoxicity and auditory toxicity of tobramycin and amikacin.
Antimicrobial agents and chemotherapy 1983;23(6):897-901.
1982: A Martinez-Vea; José M Gatell; F Segura; C Heiman; M Elena; Antonio M Ballesta; M R Mundo
Diagnostic value of tumoral markers in serous effusions: carcinoembryonic antigen, alpha1-acidglycoprotein, alpha-fetoprotein, phosphohexose isomerase, and beta 2-microglobulin.
Cancer 1982;50(9):1783-8.
1981: F Segura; L Zamora; M Sasal; Josep Mensa; José M Gatell; Eladio Soriano; J García San Miguel
[Fever of unknown origin: true dimensions of the diagnostic problem (author's transl)].
Medicina clínica 1981;77(4):150-2.
1981: José M Gatell; J M Miro; M Sasal; O Ferrer; M Rodriguez; J Garcia San Miguel
Legionella pneumophila antigen in brain.
Lancet 1981;2(8239):202-3.